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ABSTRACT OF THE DISSERTATION
Transcriptional Regulation of the Endoplasmic Reticulum in
Dedicated Secretory Cells
by
Benjamin D. Moore
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Cell Biology
Washington University in St. Louis, 2015
Professor Jason Mills, Chair
Differentiating cells express subsets of genes to build the cellular machinery necessary to
perform their specific function as they acquire their mature fate. These subsets of genes are
regulated by networks of transcription factors as cells progress through their developmental
program. In secretory tissue, highly-specialized cells establish an extensive secretory apparatus
and scale up their cellular architecture to facilitate the production and secretion of large amounts
of protein. Here, we identify a network of transcription factors required for the development of
this cellular machinery in these cells, and develop new tools to elucidate the molecular networks
that control the differentiation of secretory cell lineages.
We show that the expression of Xbp1, a transcription factor responsible for establishing
and maintaining the ER in gastric zymogenic (chief) cells (ZCs), is enhanced by HNF4α. HNF4α
directly binds the Xbp1 promoter and is sufficient to enhance its expression in gastric epithelial
cells. We observe that loss of HNF4α disrupts normal differentiation in the gastric epithelium,
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and causes morphological changes similar to the loss of XBP1, suggesting it acts through Xbp1
to maintain homeostasis in the mouse stomach.
To facilitate the study of the molecular underpinnings of ZC differentiation, we sought to
develop a technique to isolate pure ZC populations from the gastric mucosa. Using a microarraybased screen, we identified ANPEP as a surface marker of mature ZCs that enabled us to sort
homogenous ZC populations using flow cytometry. We found that ANPEP is rapidly lost as ZCs
dedifferentiate in response to damage or disease in both mouse and human models, and our
improved method allowed us to use flow cytometry to quantify these molecular changes to the
ZC surface.
We found that HNF4α is required for maintenance of the gastric epithelium, but it has
also been well-established that HNF4α plays a pivotal role in pancreatic beta-cell function.
Mutations in HNF4α cause a prevalent subset of inheritable diabetes, MODYI. However, the
mechanism through which mutated HNF4α causes beta-cell dysfunction has not yet been
established. Our data shows that HNF4α is required for expression of both Xbp1, and
downstream targets of XBP1, and that loss of HNF4α leads to diminished ER morphology in
mouse beta-cells. We show data suggesting that the loss of glucose-stimulated insulin secretion
in MODYI may be due to impaired calcium signaling from the ER, and that restoring Xbp1
expression is sufficient to rescue insulin secretion in HNF4α-null beta-cells.
Taken together, the data presented below characterizes an important new transcriptional
relationship in both the stomach and endocrine pancreas, and establishes new tools for the study
of secretory cells. These results illustrate how the study of a basic transcriptional relationship can
have broad implications in the development and treatment of prevalent human diseases.
xii

CHAPTER ONE
Preface
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Introduction
Mature secretory cells require extensive cellular machinery to synthesize, process, and
secrete large amounts of proteins. In contrast, the progenitor cells that give rise to professional
secretory cells are relatively smaller and less complex. The establishment and maintenance of
this robust secretory apparatus is coordinated at a molecular level by signaling networks that
activate or repress transcription factors (TFs); which in turn sculpt the differentiation landscape
of each cell by tightly controlling gene expression. The following will define the unique role of a
novel transcriptional cascade required for the development of mature secretory cells, describe an
exciting new tool to study these cells, and finally show the consequences of disrupting this
regulatory pathway in human disease (Fig 1).
The Secretory Pathway
Professional secretory cells are highly-specialized to secrete incredible amounts of
protein. The pancreatic beta cell, for instance, secretes over one million molecules of insulin per
minute when stimulated by glucose.(Henquin and Meissner, 1984) Expression of genes encoding
proteins that function in the secretory pathway are tightly regulated during specific stages of cell
differentiation.(Coutinho et al., 2004; Dunne et al., 2002; Schotman et al., 2009) This leads to a
substantial increase in subcellular resources i.e. organelles. For instance the Golgi apparatus
increases in volume during secretory cell maturation, enabling it to process, sort, and package
polypeptides more efficiently. (Guo and Linstedt, 2006; Jackson, 2009) Intuitively, intracellular
stores of secretory vesicles are also significantly increased in terminally differentiated secretory
cells.(Boquist, 1970; Caro and Palade, 1964) Arguably the most important feature of secretory
cells is a vast, highly-developed endoplasmic reticulum (ER). Secretory and transmembrane
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proteins are synthesized and undergo post-translational modifications in the ER.(Palade, 1956)
To accommodate the increase in cargo load during differentiation, a transcriptional cascade
propagates both an increase in size and a change in composition of the ER.(Farhan et al., 2008;
Forster et al., 2006; Iwakoshi et al., 2003) The well-regulated development and maintenance of
the ER in the mature secretory cell is paramount to both form and function.
Maintenance of ER Homeostasis
Formation of the vast ER network required by secretory cells is regulated both
developmentally and acutely, in response to ER stress. Synthesis, processing, and transport from
the ER to the Golgi apparatus is the rate limiting step in secretion for many proteins. When the
flux of nascent polypetides into the ER exceeds the capacity of the ER to fold, process, and
transport protein to the Golgi, the acute- unfolded protein response (UPR) pathway is activated.
The UPR increases the biosynthetic pathway and decreases the burden on the ER, maintaining
homeostasis.(Selye, 1985) To increase the folding capacity of the ER, the UPR spurs an increase
in the synthesis of molecular chaperones and foldases in the ER lumen,(Kozutsumi et al., 1988)
and induces ER biogenesis, increasing the volume of the ER to dilute the increased unfolded
cargo.(Cox et al., 1997; Dorner et al., 1989) The UPR also alleviates ER stress by decreasing the
biosynthetic load, downregulating the transcription and translation of genes that encode secretory
proteins (Harding et al., 1999) and removing misfolded proteins through ER-associated
degradation (ERAD).(Travers et al., 2000) While this acute response to an increased cargo load
is very well studied, the developmental regulation of the ER remains poorly understood.
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XBP1 and the ER
A principal component of the UPR pathway is the bZIP TF, X-box binding protein 1
(XBP1, first identified in yeast as HAC1p). (Cox and Walter, 1996) Canonically, XBP1 activity
is activated via a post-transcriptional splice event. Accumulation of unfolded/misfolded proteins
activates the ER transmembrane endonuclease inositol requiring kinase 1 (IRE1).(Liu et al.,
2002) Activated IRE1 splices a small intron from Xbp1 mRNA, allowing translation of
functional XBP1 protein (XBP1s) and subsequent translocation to the nucleus where it activates
a large network of genes that encode proteins vital for ER biogenesis, protein folding, and
formation of the cell’s secretory apparatus(Fig. 2). (Acosta-Alvear et al., 2007) While the
regulation of XBP1 in acute ER stress conditions has been extensively studied, regulation and
function of XBP1 in the development and maintenance of the ER is not well defined. The
transcriptional regulation of Xbp1 may be as important to its role in secretory cell development
as its activation by IRE1. Xbp1 expression is significantly elevated in secretory cells, and large
pools of unspliced Xbp1 mRNA are required to restore homeostasis in chronic ER stress
conditions, e.g. the large biosynthetic load of professional secretory proteins.(Ogawa and Mori,
2004) Additionally, IRE1 is basally activated in dedicated secretory cells at levels comparable to
acute ER stress in non-secretory cells (>40%).(Yang et al., 2010) When the presumably UPRactivating biosynthetic load-stimulus is removed in Β-cells differentiating to plasma cells by
disrupting expression of IgM, XBP1 is still activated, indicating that XBP1 activation is
differentiation-dependent rather than UPR-dependent in secretory cells.(Bonnefous et al., 2009)
Together, these data suggest that transcription of Xbp1 is the rate-limiting step in its activation
during the differentiation of secretory cells.
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Regulation of Secretory Cell Differentiation by XBP1
XBP1 has been characterized as an important transcriptional regulator of the
differentiation of dedicated secretory cells in the pancreas, stomach, and intestine.(Huh et al.,
2010; Kaser et al., 2008; Lee et al., 2005; Lee et al., 2011) As expected, because of its
developmental regulation and its role in cell-differentiation, XBP1 has been shown to act in a
developmental transcriptional cascade in secretory cells unrelated to ER function. XBP1 directly
enhances the transcription of the TF Mist1 in secretory tissue.(Huh et al., 2010) MIST1 is a TF
that regulates a subset of genes encoding proteins that scale up cellular machinery and
architecture dedicated secretory cells.(Pin et al., 2001) Loss of Mist1 in gastric or pancreatic
acinar cells leads to reduced cell and secretory granule size, altered subcellular organization, and
disruption of the downstream secretory apparatus,(Jin and Mills, 2014; Ramsey et al., 2007; Zhu
et al., 2004) however, MIST1 has no known role in ER function. The regulation of Mist1 by
XBP1 shows that XBP1 is not only a main component of the UPR pathway, but also an
important factor in the differentiation of professional secretory cells.
Despite the significance of the transcriptional regulation of Xbp1 in the secretory cell, and
the key role XBP1 plays in development, little is known about what regulates Xbp1 expression.
In ER stress conditions, the TF ATF6 is activated and able to enhance Xbp1 expression, (Lee et
al., 2002) and XBP1 can synergistically stimulate its own expression, (Ogawa and Mori, 2004)
though this regulatory pathway is likely more important to the UPR, and not to developmental
patterning. In plasma cells, the TF Blimp1 is required for XBP1 expression, and activation of this
transcriptional cascade enlarges the ER and secretory apparatus.(Shaffer et al., 2004) Recently,
the TF Hnf1a has been shown to enhance Xbp1 expression in pancreatic beta-cells.(Kirkpatrick
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et al., 2011) Delineating the mechanism of Xbp1 regulation in secretory cells will lead to a better
understanding of cell differentiation and homeostasis in both normal and pathological states.
Secretory Cell Differentiation in the Gastric Epithelium
Disruption of secretory cell development and homeostasis underlies many prevalent
diseases and malignancies. Understanding the molecular pathways and signaling networks that
guide normal secretory cell differentiation and how these pathways are altered in disease states
will lead open new avenues to the treatment and prevention of myriad pathologies. In the
following chapters, I characterize the developmental role of a novel transcriptional cascade,
focusing on dedicated secretory cells in two distinct tissue; first the stomach, and finally the
pancreas. The professional secretory cell in the gastric epithelium is the zymogenic (chief) cell
(ZC).(Karam and Leblond, 1993) Damage or disease to the stomach leads to a rapid
dedifferentiation event in ZCs, where these formally terminally differentiated secretory cells
begin to re-express progenitor markers, disassemble their secretory machinery through
autophagy, and re-enter the proliferative cycle.(Aikou et al., 2009; Nam et al., 2010; Nozaki et
al., 2008) In environments of chronic stress in the gastric epithelium, this aberrant
dedifferentiation leads to precancerous metaplasia.(Goldenring et al., 2010)

Defining the

molecular pathways that orchestrate the differentiation and maintenance of normal ZCs is key to
demarcating the factors that drive the formation of this metaplasia, and may uncover the key to
slowing or reversing the progression to gastric cancer.
Xbp1 is one of the few known transcriptional regulators of ZC development. Loss of
Xbp1 in mouse adult gastric corpus epithelium leads to a collapse of the ZC architecture; the ER
degrades from a tightly-packed, well organized network to a sparse, free structure, Mist1
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(another TF important to ZC differentiation)(Ramsey et al., 2007) expression is no longer
induced, and new ZCs fail to mature from precursor cells.(Huh et al., 2010) Because of the
indispensable role of Xbp1 in ZC development, and the evidence discussed above demonstrating
the importance of the transcriptional regulation of Xbp1, I sought to identify a TF that directly
regulates Xbp1 expression. In “Chapter 1”, I provide evidence that hepatic nuclear factor 4-alpha
(HNF4α) is a direct regulator of Xbp1, and characterize its role in the gastric epithelium. The
novel transcriptional regulation of Xbp1 by HNF4α is the cornerstone of this thesis, and has
many important implications in the field of secretory cell development.
The Master Developmental Regulator, HNF4α
The nuclear hormone receptor HNF4α is a master developmental regulator of several
secretory tissues. Loss of Hnf4α results in embryonic lethality in mouse models, as it is required
for proper gastrulation.(Chen et al., 1994) Tissue-specific knockouts of the Hnf4α gene have
established its importance in the development and maintenance of many secretory tissues.
HNF4α is required for both the development of the intestine,(Babeu et al., 2009; Garrison et al.,
2006) and maintenance of its secretory cell-homeostasis, architecture, and function.(Cattin et al.,
2009) Interestingly, human patients with inflammatory bowel (Crohn’s) disease have low levels
of HNF4α expression, and loss of HNF4α has been used as a model of colitis in mice.(Ahn et al.,
2008; Darsigny et al., 2009) Similarly, tissue-specific knockouts have shown that HNF4α is a
crucial component in the initial embryonic development and maintenance of the adult
liver.(Battle et al., 2006; Hayhurst et al., 2001; Parviz et al., 2003) In the adult pancreatic betacells, HNF4α is required for proper secretion of insulin in response to glucose.(Gupta et al.,
2005; Miura et al., 2006) Correspondingly, mutations in HNF4α in human patients have been
shown to cause a subset of diabetes called Mature-Onset Diabetes of the Young Type-1 (an
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aspect of HNF4α biology that will be described at length below).(Yamagata et al., 1996) The
fundamental role of HNF4α in these tissues and human disease has led to an incredible wealth of
studies defining its structure,(Chandra et al., 2013) preferred binding sequences and
partners,(Fang et al., 2012; Misawa et al., 2003) expression variants,(Drewes et al., 1996) and its
regulatory interplay with other related transcription factors.(Odom et al., 2004) Despite these
efforts, the molecular mechanisms through which HNF4α maintains secretory cell identity and
function are not well understood. Additionally, despite the high level of Hnf4α expression in the
gastric epithelium and its pivotal role in the maintenance of closely related secretory tissue e.g.
the intestine and pancreas,(Dean et al., 2010) the function of HNF4α has never been explored in
the stomach. In chapter 1, I present data suggesting that HNF4α acts through enhancing Xbp1
expression to maintain secretory cell identity, and that HNF4α is required for the maintenance of
the gastric epithelium.
Gastric cancer is the third-leading cause of cancer-related mortalities worldwide.(Ferlay
et al., 2015) However, the events that drive the progression from a healthy gastric epithelium, to
precancerous metaplasia, and finally to the development of adenocarcinoma are not well
understood. A major obstacle to elucidating the molecular underpinnings of secretory cell
development in the normal and metaplastic stomach is the difficulty of isolating individual cell
populations from the epithelium. Like all secretory tissues, the stomach comprises a number of
distinct cell lineages. Unlike other secretory tissues, however, the tools to isolate these lineages
are cumbersome and underdeveloped. These difficulties are compounded by a lack of molecular
markers with which to identify each cell type. In chapter 2, I describe a novel surface marker of
fully differentiated ZCs in mouse and human stomach, and describe an improved method to
isolate pure populations of ZCs from the gastric epithelium using this marker. This approach
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allows not only efficient isolation of gastric ZCs, but also enables the characterization of
molecular changes in response to damage or disease.
Mature-Onset Diabetes of the Young Type-1 and the ER
The transcriptional regulation of Xbp1 expression by HNF4α is likely important to the
development of secretory cells in several tissues, perhaps most importantly in the endocrine
pancreas. Polymorphisms in Hnf4α are the cause of MODYI, a subset of diabetes characterized
by diminished glucose-stimulated insulin secretion (GSIS) in pancreatic beta-cells. MODY
accounts for 2-5% of total diabetes cases, though often it remains undiagnosed.(Porter et al.,
2006; Shields et al., 2010) The mechanism by which HNF4α dysfunction causes MODYI
pathology is unclear. The data presented in chapter four suggests that the transcriptional
activation of Xbp1 expression by HNF4α is necessary for beta-cell function.
The pancreatic beta-cell is a finely-tuned secretory machine. Once stimulated with
glucose, the beta-cell increases insulin synthesis 10-fold, accounting for 50% of the cell’s total
protein synthesis.(Schuit et al., 1988) This biosynthetic load creates an incredible burden on the
ER, and subsequently small aberrations in beta-cell ER function lead to dysfunction and
apoptosis.(Eizirik et al., 2008; Gurzov et al., 2009) A rare genetic form of type I diabetes,
Wolcott–Rallison syndrome, is caused by a loss of function mutation in a key protein (PERK) in
the UPR signaling cascade. (Rubio-Cabezas et al., 2009) This disruption of PERK function
causes a diminished UPR, and subsequently β-cell apoptosis. Wolfram syndrome, another rare
genetic form of diabetes, is usually caused by mutations in the WFS1 gene. (Fonseca et al., 2010)
The protein encoded by this gene is important for proper ER stress response, and the
pathogenesis of Wolfram syndrome is most likely due to chronic, unmitigated ER stress that
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leads to β-cell death. The pathology of type II diabetes is driven by peripheral insulin resistance,
which provokes a sustained, increased synthesis and secretion of insulin in β-cells. This
increased biosynthetic load in the ER of β-cells instigates prolonged ER stress, and likely leads
to decreased β-cell function in patients genetically susceptible to ER stress. Interestingly, recent
genomic studies have shown patients with point mutations in ER stress factors have an increased
susceptibility to type-II diabetes.(Sandhu et al., 2007) Pathological ER stress induced by longterm exposure to high glucose levels alters ER-calcium homeostasis, disrupting intracellular
signaling and causing cell death.(Hara et al., 2014) Similiarly, genome-wide association studies
have also linked polymorphisms in Hnf4α to increased susceptibility to type-II diabetes. Similar
to MODYI mouse-models, beta-cell-specific knockouts of Xbp1 in adult mice are unable to
secrete insulin in response to a glucose stimulus.(Lee et al., 2011) Chapter four outlines the
importance of the relationship between Xbp1 and HNF4α to beta-cell function, and outlines the
first-clear molecular mechanism of MODYI pathology.
Summary
The transformation of a cell from a small multipotent progenitor to a large and complex
professional secretory cell is meticulously orchestrated by a network of developmental
regulators. Defining the signaling networks and factors that guide this differentiation is pivotal to
understanding how these pathways are disrupted in disease, and to providing new therapeutic
avenues for the many maladies associated with secretory cell dysfunction, from cancer to
diabetes. Here, we identify one such signaling cascade, HNF4α →Xbp1, responsible for the
development and homeostasis of secretory cells in multiple tissues. In this thesis, we:
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1. Define HNF4α as a direct transcriptional regulator of Xbp1, required for
secretory cell homeostasis in the gastric epithelium.
2. Identify a novel surface marker of ZCs in the gastric epithelium, allowing
cell-lineage specific isolation and characterization in normal and diseased
stomachs.
3. Establish that HNF4α directly enhances Xbp1 expression in beta-cells, and
that this relationship is required for ER homeostasis, glucose-stimulated
insulin secretion, and intracellular signaling, defining the first clear molecular
mechanism for MODYI pathology.
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Figure Legends
Figure 1. Overview. The differentiation from a relatively simple progenitor cell to a large,
complex professional secretory cell is orchestrated by transcriptional network that coordinate the
establishment of secretory machinery, and remodel cellular architecture to facilitate production
and secretion of large amounts of protein. We have A) identified one of these networks,
HNF4α→Xbp1, and found it to be indispensable to normal differentiation in the gastric
epithelium B) developed a new set of tools to isolate and better characterize secretory cells in the
stomach, and C) identified the role of HNF4α→Xbp1 in beta-cell dysfunction during human
disease.
Figure 2. Regulation of Xbp1 in response to ER stress. In response to an increased secretory load,
misfolded proteins accumulate in the ER lumen. This activates the UPR by causing
phosphorylation and dimerization of IRE1, which in turn splices and activates XBP1. Once
activated XBP1enters the nucleus and enhances expression of a genes that increase the secretory
capacity of the ER and alleviate ER stress. Adapted from (Pandol et al., 2011)
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Abstract
Little is known about the molecular pathways that orchestrate the differentiation of the
gastric epithelium. Our lab has identified a transcriptional cascade, XBP1→Mist1, which
regulates the development of gastric-enzyme secreting ZCs in the gastric unit. Here, we show
that HNF4α acts upstream of Xbp1 in ZC development. Using an in silico screen of
evolutionarily conserved regions of the Xbp1 promoter, we identified two potential HNF4α
binding sites. Using chromatin immunoprecipitation, we show that HNF4α directly occupies the
Xbp1 locus. We found that by overexpressing HNF4α in a gastric cancer cell line, Xbp1
expression increased, suggesting that HNF4α is sufficient for Xbp1 expression.
Immunofluorescent staining of HNF4α showed that it is expressed in gastric pit, isthmal
progenitor, neck, and zymogenic cells, but not in parietal cells. Using a tamoxifen-inducible cre
system, we show that loss of HNF4α in the adult stomach led to increased proliferation, reduced
ZC size and ER formation, and aberrant differentiation. These data show that HNF4α is an
important regulator of differentiation and a transcriptional enhancer of Xbp1 expression in the
stomach.
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Introduction
The mammalian gastric epithelium is an organized network of cells which function to
secrete mucus, acid, and digestive enzymes into the gastric lumen. These cells are located in
repeating glandular invaginations called gastric units. Based on anatomy and cell function each
unit can be divided into four distinct sections: the pit zone opens into the gastric lumen and
contains mucus-secreting pit cells; the isthmus region houses stem cells and early progenitors;
the neck zone contains both acid-secreting parietal cells (PC) and mucus-secreting neck cells;
and the base zone contains digestive-enzyme secreting zymogenic cells (ZCs). (Fig. 1A) The
differentiation of each lineage has been characterized by detailed morphological studies and
analysis of gene expression patterns, which are conserved in each gastric unit (Karam,1993;
Karam and Leblond, 1993a, b, c, d). The gastric unit is a uniquely well
suited system to study transcriptional regulators of cell differentiation and morphology, because
development of each cell type is tightly controlled along a well-defined spatiotemporal gradient.
The molecular mechanisms that control these changes in expression and morphology are largely
uncharacterized in the stomach. The best example of this process is the formation of ZCs, which
arise from mucus neck cells. As ZCs differentiate from their progenitor neck cells, a cascade of
transcription factors is activated that include XBP1 and MIST1.(Huh et al., 2010; Ramsey et al.,
2007) Elucidation of the factors that orchestrate epithelial differentiation will shed light on
fundamental cellular processes, and give insight on how pathological conditions like metaplasia
and gastric atrophy develop. Understanding these transcriptional regulators is essential to
developing new ways to treat and prevent gastric cancer.
Our lab has previously identified the transcription XBP1 as a regulator of the maturation
of ZCs that occupy the base of the gastric unit.(Huh et al., 2010) XBP1 controls the
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differentiation of ZCs by induction of the TF MIST1 and the expansion of the rough
endoplasmic reticulum. When Xbp1 is conditionally deleted in mice using a tamoxifen/Cre-loxP
system, Xbp1-null ZCs decrease in size, and MIST1 expression is lost; the gastric units resemble
those of mice with pseudopyloric or spasmolytic polypeptide expressing metaplasia (SPEM), a
well-established precursor to stomach cancer. To further explore the molecular networks that
drive ZC differentiation, we sought to elucidate TFs that act upstream of XBP1 in the ZC
signaling cascade. We found that Xbp1 expression is enhanced by the TF HNF4α, a master
regulator of secretory tissue development.
HNF4α is required for proper secretory cell differentiation and maintenance in many
tissues with similarities to the stomach. In the adult intestinal epithelium, loss of HNF4α results
in altered secretory cell architecture, aberrant cell differentiation, proliferation, and impaired
barrier function.(Cattin et al., 2009) HNF4α is also required to maintain cell differentiation in the
colon, and disruption of its expression leads to inflammation, proliferation, and cell
dedifferentiation.(Darsigny et al., 2009) Similarly, loss of HNF4α in the adult mouse liver leads
to altered cell differentiation, causing hepatocytes to dedifferentiate into progenitor-like cells,
and disrupting lipid synthesis.(Hayhurst et al., 2001) Though HNF4α is known to be expressed at
high levels in the stomach, and is alternatively spliced in early gastric carcinomas,(Dean et al.,
2010; Takano et al., 2009) nothing is known about its function or importance to gastric epithelial
development and maintenance. Here, we show that HNF4α is required for the maintenance of the
ZC lineage and normal differentiation in the gastric unit.

24

Results
HNF4α directly enhances Xbp1 expression. To identify potential regulators of
Xbp1expression, we performed an in silico screen, scanning evolutionarily conserved regions of
the Xbp1 promoter locus for known TF binding sites.(Ovcharenko et al., 2005) We identified two
putative HNF4α binding sites upstream of the Xbp1 transcription start site. To determine whether
HNF4α directly bound these sites, we performed chromatin immunoprecipitation. Cells from a
gastric cancer cell line (AGS) were transiently transfected with an expression vector containing
HNF4α. These cells were then crosslinked and immunoprecipitated with an HNF4α antibody or
serum control. HNF4α occupied both predicted sites in the XBP1 promoter (Fig. 1A). The site
located -1.6 kb from the transcription start site showed strong occupation of HNF4α as assayed
with two different antibodies. The site -2.4 kb upstream showed weaker occupation, and the
intronic control site showed no HNF4α occupation. To determine the function of HNF4α in XBP1
regulation, we used isolated protein from AGS cells transiently transfected with two common
splice variants of HNF4α and measured the expression of XBP1 by immunoblot. XBP1
expression was dramatically increased in cells transfected with HNF4α compared to a GFP
control plasmid (Fig. 1B,C), indicating that HNF4α is a direct transcriptional enhancer of XBP1.
HNF4α is expressed in the isthmus, pit, neck, and zymogenic cells in the gastric corpus.
Similar to the situation in other endoderm-derived secretory tissues, HNF4α has been shown to
be highly expressed in the gastric epithelium.(Dean et al., 2010) However, the specific cell
lineages that express HNF4α have not been determined. Understanding which cell types express
HNF4α will give us a better understanding of the molecular mechanisms of HNF4α in the
maintenance and development of the stomach. We used immunofluorescent microscopy on
mouse stomach tissue to determine the pattern of HNF4α expression, and found that HNF4α was
expressed highly in progenitor cells in
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the isthmus and pit cells, and at lower levels in cells expressing the neck cell marker and ZCmarking GIF (Fig. 2A,B). HNF4α was not, however, expressed in parietal cells.
HNF4α is required for maintenance of the gastric epithelium. Because HNF4α was
expressed highly in the stomach, we sought to determine its function by knocking out HNF4α
expression in the adult mouse gastric epithelium. We generated a mouse model of acute loss of
HNF4α by crossing the tamoxifen inducible CAGCreERT mice, previously shown by our group to
be an efficient driver of cre recombination in the gastric epithelium,(Huh et al., 2010) to mice
containing a floxed Hnf4α allele.(Hayhurst et al., 2001) This model allowed us to induce loss of
HNF4α via injection of low-dose(1mg/20g mouse) tamoxifen. Loss of HNF4α led to a ~4 fold
increase in proliferation, measured by ki67 expression and Brdu staining (Fig. 3A,B). This
increased proliferation did not, however, lead to an increase in unit length (data not shown) or
overall area (Fig. 4A), as we had expected. The most striking phenotype was a dramatic change
in ZC morphology. The base/ZC region was significantly diminished (Fig. 4B), and the ZCs in
ΔHNF4α mouse stomachs were half the size of WT ZCs (Fig. 4C). Additionally the overall
census of ZCs was ~25% lower in the HNF4α KO (Fig. 4D). These changes in unit morphology
are evident when comparing WT and ΔHNF4α hematoxylin and eosin stained tissue from the
gastric corpus (Fig. 5A). The dark-staining ZC region is noticeably collapsed (highlighted by
white arrowheads, Fig. 5A) when HNF4α is lost. Interestingly, this collapse mimics loss of
XBP1 observed in previous work (Fig. 5B, adapted from (Huh et al., 2010)). Because of the
transcriptional relationship between Xbp1 and HNF4α, and the role of XBP1 in maintaining the
ER, we expected loss of HNF4α to result in diminished ER in the gastric epithelium.
Accordingly, the ER (as measured by expression of the ER-localized protein, Calregulin) was
significantly reduced in size upon loss of HNF4α (Fig. 5C).
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The ZC transitions from a proliferative progenitor cell, to a neck cell, and finally to its definitive
form as the stomach’s professional secretory cell in the normal gastric epithelium. Because of its
role in other tissues as a master regulator of secretory cell differentiation, and its regulation of
Xbp1, an important player in ZC differentiation, we hypothesized that disrupting HNF4α in the
stomach would result in aberrant differentiation in the gastric unit. As expected, we observed
precursor neck cells in the base of the gastric unit in ΔHNF4α mice (white arrowhead, Fig. 6A),
a phenomenon that is rarely observed in WT mice. Both the average distance of neck cells from
the basal membrane (Fig. 6B) and the percentage of ZC-regions (which generally contain no
neck-cells in WT mice, Fig. 6C) were significantly different upon loss of HNF4α, with almost a
quarter of ΔHNF4α ZC regions exhibiting neck cell intrusion. These data indicate that HNF4α is
required for the normal differentiation of the gastric epithelium.

27

Discussion
We show here that HNF4α is expressed in pit, isthmal, neck, and zymogenic cells in the
gastric corpus, and that it is required for normal differentiation. Additionally, HNF4α is a
direct transcriptional regulator of Xbp1 expression, suggesting that upregulation of Xbp1 is one
of the mechanisms through which HNF4α regulates ZC development. To our knowledge, this
is the first time the role of HNF4α in the stomach has been described.
Relatively few transcriptional regulators responsible for gastric epithelial development
have been previously identified. Characterizing such factors and the signaling networks which
they govern is key to understanding how to target maladies resulting from their dysregulation,
e.g. cancer. The transcriptional enhancement of Xbp1 by HNF4α in the stomach is a potentially
important finding for 3 reasons: 1) it adds an upstream component to the only well-defined
signaling cascade that orchestrates ZC differentiation HNF4α→XBP1→MIST1, aberrations in
which lead to metaplastic-like gastric mucosa, 2) it builds further upon and the developing
concept that tight regulation of Xbp1 expression is not just important for the unfolded protein
response but is also pivotal to its role as a developmental coordinator of secretory cell
differentiation, and 3) many of the effects of loss of HNF4α in other secretory tissues (i.e. liverdyslipidemia, intestine-secretory cell architecture, β-cell-secretory dysfunction) may be caused
in part by this novel relationship. Future experiments further characterizing this signaling
cascade, and the molecular mechanisms by which HNF4α orchestrates other aspects of the
development and maintenance of the gastric epithelium have potential to uncover fundamental
mechanisms of disease development in the stomach and other secretory tissues.
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Methods
Cell lines and Transient Transfection
AGS cells (from ATCC, Manassas, VA) were grown in RPMI 1640 supplemented with
10% fetal bovine serum, 0.9% glutamine, 0.4% HEPES, 1% Na pyruvate, 2.5% glucose, and 100
ng/ml each of penicillin and streptomycin. For overexpression of myc-tagged HNF4α2 or
HNF4α8, coding regions (obtained from addgene) were subcloned into a pcDNA3.1expression
vector, and 5μg of each plasmid or the pmaxGFP(lonza) control plasmid were transiently
transfected using TransIT-2020 (Mirus, Madison, WI). For siRNA we transfected MIN6 and
INS-1 cells with 10nM HNF4α siRNA (silencer select Invitrogen) using Lipofectamine 2000
according to the manufacturer’s protocol.
Western Blot
Cells for western blot analysis were lysed in RIPA buffer. Proteins were quantified by
DC protein assay (Bio-Rad) and then separated on NuPAGE Bis-Tris gels (Invitrogen),
transferred onto Amersham Hybond ECL nitrocellulose (GE Healthcare, Buckinghamshire, UK)
membranes, and detected by Immobilon chemiluminescence (Millipore). Primary antibodies
used were rabbit anti-XBP1(Santa Cruz), mouse anti-c-myc (dshb), and rabbit anti-α- and βtubulin (Cell Signaling). Secondary antibodies were horseradish-peroxidase-conjugated donkey
anti-rabbit and anti-mouse Ig (Santa Cruz Biotechnology, Santa Cruz, CA). Quantifications of
immunoblots were performed by scanning 16-bit images into ImageJ. Band intensities for XBP1
and α/β tubulin were selected and calculated by using the ‘Analyze mean gray value’
measurement tool. Standardized values were calculated determining the ratio of XBP1 signal to
α/β tubulin signal.
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Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as described previously.(Im et al.,
2004) Approximately 106 AGS cells transiently transfected with HNF4α expression vector as
described above were used for this ChIP experiment. Ten microliters of anti-HNF4α (rabbit antihuman MIST1) or whole rabbit serum (preimmune control) together with protein A/G plus
agarose (Santa Cruz Biotechnology) was added to the homogenized tissue for
immunoprecipitation. Quantitative real-time PCR (qRT-PCR) was performed to assess the
quantity of genomic sequences immunoprecipitated by either preimmune control or HNF4α
antiserum, as well as a 1:10 dilution of the cell extract prior to immunoprecipitation (input). Two
predicted HNF4α binding sites8 were probed in addition to an intronic control region with no
predicted HNF4α binding sites nearby.

Mouse Studies
All experiments involving animals were performed according to protocols approved by
the Washington University School of Medicine Animal Studies Committee. Floxed Hnf4α,
CAGGCreERTM transgenic mice were generated by crossing Hnf4αfloxed/floxed mice (a gift from
Frank Gonzalez, NIH)(Hayhurst et al., 2001) with CAGGCreERTM;Hnf4αfloxed/+(Hayashi and
McMahon, 2002) mice to allow systemic, tamoxifen-inducible knock out of HNF4α. 6-8 week
old CAGGCreERTM;Hnf4αfloxed/floxed mice and CAGGCreERTM;Hnf4αfloxed/+ littermate controls
were injected intraperitoneally with tamoxifen (1mg/20g body weight, 5 consecutive days) to
induce cre-mediated Hnf4α deletion. Mice were sacrificed 4 weeks after first tamoxifen
injection.
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Immunofluorescence and Quantification
Stomachs were prepared and stained as described previously.(Ramsey et al., 2007)
Stomachs were inflated with 10% formalin fixative and suspended in fixative for 4 hours at room
temp. Tissue was rinsed with 70% EtOH multiple times, arranged in 2% agar in tissue cassettes,
and paraffin processed. Sections (5µm) were deparaffinized and rehydrated, and antigen retrieval
was performed by boiling in Trilogy Buffer (Cell Marquee Corporation). Slides were blocked in
1% BSA, 0.3% Triton X-100 in PBS, then incubated in primary followed by secondary
antibodies and with fluorescently labeled lectin Griffonia simplicifolia-II (neck cell-specific GSII; 1:1,000; Invitrogen). Finally, slides were incubated for 5 min in 1µg/mL bisbenzimide
(Invitrogen) prior to mounting in 1:1 PBS-glycerol. Primary antibodies used for immunostaining
were: goat anti-Calregulin (1:200, Sigma), goat anti-human gastric intrinsic factor (GIF)
(1:2,000; gift of Dr. David Alpers, Washington University), rabbit anti-HNF4α (1:100 Cell
Signaling), goat anti-BrdU (1:2,000; gift of Dr. Jeff Gordon, Washington University), rabbit antiKi67 (AbCam) and sheep anti-PGC (1:10,000; Abcam).
For morphological analysis, sections were stained with hematoxylin and. Whole
slides were scanned with Nanozoom microscope and every 5th unit was measured across each
slide using Nanozoom Digital Pathology software (Hamamatsu). Samples were randomized,
and the scorer was blinded to ensure unbiased quantification.
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Figure Legends
Figure 1. HNF4α directly enhances Xbp1 expression. A) Chromatin Immunoprecipitation from
AGS cells transiently transfected with an HNF4α expression plasmid. Two different antibodies
(α-HNF4α-1, α-HNF4α-1) both showed significant binding of HNF4α to two predicted sites in
the Xbp1 promoter when compared to serum control. B,C) Western blot and band intensity
quantification of protein isolated from AGS cells transiently transfected with one of two HNF4α
expression plasmids or a GFP control plasmid shows XBP1 expression is enhanced by HNF4α.

Figure 2. Expression of HNF4α in the gastric epithelium. A) HNF4α (green) is expressed in
isthmal progenitor, pit, neck(purple), and zymogenic (red) cells of the mouse gastric corpus. B)
Pit/isthmal region shows intense staining of nuclear HNF4α

Figure 3. Loss of HNF4α leads to increased proliferation in the gastric epithelium. A)
Proliferation marker Ki67 (green) in WT and ΔHNF4α mouse gastric corpus. B) Quantification
of BrdU incorporation in WT and ΔHNF4α mouse stomachs

Figure 4. Loss of HNF4α causes altered ZC morphology. A) Quantification of total area of the
gastric unit. B) Quantification of the ZC-containing region at the base of the gastric unit,
normalized to total unit area. C) Quantification of the total area/ZC obtained by dividing the area
of the ZC region by the number of ZCs. D)Total number of ZCs/unit. All experiments represent
Mean±SEM of three biological replicates.
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Figure 5. Loss of HNF4α leads to diminished ER, resembling loss of XBP1. A)H&E staining of
mouse gastric epithelium in WT and ΔHNF4α mice. White arrowheads highlight the ZCcontaining base region, which is noticeably collapsed in ΔHNF4α mice. B) E staining of mouse
gastric epithelium in WT and ΔXBP1 mice. Like HNF4α, the base region is noticeably collapsed
upon loss of XBP1. C) Immunofluorescent stain of the ER marker, Calregulin (red), in ZCs of
WT and ΔHNF4α mice. ΔHNF4α mice have significantly reduced ER.

Figure 6. Neck cell intrusion in ΔHNF4α mice. A) Neck cells (green) in ΔHNF4α mice are
inappropriately present in the ZC region (red) of the gastric unit. B) Quantification of the average
distance from the base of the unit to the unit’s first neck cell. C) Quantification of the percentage
of ZC regions containing neck cells.
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CHAPTER THREE
Identification of ANPEP as a Surface Marker
for Isolation of Mature Gastric ZCs

41

Identification of Alanyl Aminopeptidase (CD13) as a Surface Marker for
Isolation of Mature Gastric Zymogenic Chief Cells

Benjamin D. Moore1, Ramon U. Jin1, Judith Romero-Gallo2, Jennifer Noto2, Richard M. Peek
Jr.2, Jason C. Mills1

1

Division of Gastroenterology, Departments of Medicine, Pathology & Immunology, and
Developmental Biology, Washington University, St. Louis, Missouri
2

Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University School of
Medicine, Nashville, Tennessee 37232
To whom correspondence should be addressed: Division of Gastroenterology, Dept. of Medicine,
Washington University School of Medicine, Box 8124, 660 S. Euclid Ave. St. Louis, MO 63110.
Tel.: 314-362-4258; Fax: 314-362-2505; E-mail: jmills@wustl.edu.

42

Abstract
Injury and inflammation in the gastric epithelium can cause disruption of the pathways
that guide the differentiation of cell lineages, which in turn can cause persistent alterations in
differentiation patterns, known as metaplasia. Metaplasias that occur in the stomach are
associated with increased risk for cancer. Methods for isolating distinct gastric epithelial cell
populations would facilitate dissection of the molecular and cellular pathways that guide normal
and metaplastic differentiation. Here, we identify Alanyl Aminopeptidase (ANPEP; aka CD13)
as a specific, surface marker of zymogenic chief cells (ZCs) in the gastric epithelium. We show
that: 1) among gastric epithelial cells, ANPEP expression is confined to mature ZCs, and 2) its
expression is lost en route to metaplasia in both mouse and human stomachs. With this new
marker coupled with new techniques we introduce for dissociating gastric epithelial cells and
overcoming their constitutive autofluorescence, we are able to reliably isolate pure populations
of ZCs, and observe changes in ZC differentiation ex vivo in response to epithelial damage.
Keywords: Aminopeptidase N/CD13, Zymogenic Chief Cell, Gastric Epithelium, Splasmolytic
Polypeptide Expressing Metaplasia
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Introduction
The differentiation and maintenance of each lineage in the epithelium of the body of the
mammalian stomach is orchestrated by signaling networks and molecular pathways. (Aikou et
al., 2009; Bredemeyer et al., 2009; Leys et al., 2006)The 3 most abundant differentiated cell
lineages are: the mucus-secreting pit cells near the luminal surface, the acid-secreting parietal
cells located mostly in the middle (neck) portion of each gastric unit, and the digestive enzymesecreting zymogenic chief cells (ZCs) in the base of the unit. Each cell in the gastric epithelium
is thought to derive from the same, undifferentiated population of stem cells and is replenished
throughout adulthood.(Karam and Leblond, 1993b; Werbowetski-Ogilvie et al., 2011) The ZC
has an unusual differentiation pattern, deriving from the stem cell by an intermediary form, the
mucous neck cell, which migrates amongst parietal cells for ~ 2 weeks (in mice) towards the
base before terminal differentiation into ZCs.(Bredemeyer et al., 2009; Karam and Leblond,
1993a; Ramsey et al., 2007)
Disruption of the molecular pathways regulating the differentiation of those cell lineages
through damage or disease can cause a chronic, aberrant differentiation state known as
metaplasia. In mice and humans, one of the most common such aberrations is associated with
increased risk for progression to gastric cancer and is termed, splasmolytic peptide-expressing
metaplasia (SPEM; named because the progenitor marker Spasmolytic Peptide, aka TFF2,
becomes re-expressed in ZCs, as they reprogram into a metaplastic lineage).(Nozaki et al., 2008)
SPEM in humans is associated with further potential aberrations in epithelial differentiation
patterns, like intestinal metaplasia, as well as progression to gastric cancer. (Nam et al., 2010)
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Metaplasia in the stomach, especially SPEM, is hypothesized to derive largely via the
cellular reprogramming of ZCs from a post-mitotic, terminally differentiated cell back into a
proliferative, regenerative state.(Goldenring et al., 2011; Mills and Sansom, 2015; Nozaki et al.,
2008) In certain injury/inflammatory states (in particular, in response to infection with the
bacterium Helicobacter pylori), ZCs can reprogram, meaning, they reexpress markers of their
precursor neck-cell phase and also re-enter the cell cycle to become proliferative.(Aikou et al.,
2009; Nam et al., 2010) The molecular pathways underlying ZC reprogramming may be similar
to those that govern reprogramming of other cells in other tissues during injury/repair (e.g.
pancreatic acinar cells in acinar-to-ductal metaplasia) and is currently an area of intensive
research.(Mills and Sansom, 2015) Isolating pure populations of ZCs to analyze the pathways
that lead to reprogramming would help us understand the molecular underpinnings of this newly
recognized, fundamental cellular process. Here, we identify a surface marker of ZCs that allows
the isolation of a pure population from the normal gastric epithelium, Alanyl Aminopeptidase
(ANPEP).
ANPEP is a membrane-associated protein involved in the metabolism of peptides by
diverse cell types. ANPEP null mice have significantly impaired angiogenesis in pathological
conditions,(Rangel

et

al.,

2007)

and

ANPEP

is

required

for

endothelial

cell

adhesion/invasion.(Mina-Osorio et al., 2008; Petrovic et al., 2007) ANPEP is thought to function
in the final digestion of peptides in the digestive tract, though its specific function in the gastric
epithelium is unknown.(Kruse et al., 1988) Intestinal absorption of cholesterol is impaired when
ANPEP is pharmacologically inhibited.(Kramer et al., 2005) In disease states, ANPEP
expression in colonic tumors is associated with a poor prognosis for node-positive patients with
colon

cancer,

and

aberrant

expression

of
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ANPEP

is

a

marker

for

multiple

leukemias/lymphomas.(Dalal et al., 2014; Saxena et al., 2010)

We show that ANPEP is

expressed exclusively in mature ZCs in the gastric epithelium, exploit this to both isolate pure
populations of ZCs, and document changes in the gastric epithelium in normal and metaplastic
states.
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Materials and Methods
Bioinformatic Analysis
Affymetrix Mouse Gene 1.0ST microarrays were used to analyze gene expression in each
cell lineage from RNA captured with LCM in previously performed experiments.(Capoccia et
al., 2013; Huh et al., 2012; Ramsey et al., 2007) Affymetrix Mouse Genome 430 2.0 microarrays
were used to analyze gene expression in stomachs from treated with tamoxifen or vehicle from 3
pooled mice as described below. Chip quality control and gene specific ANOVA analysis were
performed using Partek® Flow® software, version 3.0 Copyright ©; 2014 (Partek Inc., St. Louis,
MO, USA). Zymogenic cell lineage-specific expression was determined by identifying genes
that were significantly increased in ZCs (fold change >1.5) compared to other gastric epithelial
cell lineages. To enrich for potential surface markers, ZC specific genes were filtered with Gene
Ontology (GO) terms “membrane”, “integral component of membrane”, and “external side of
plasma membrane”.

Animals
Experiments involving animals were conducted according to protocols approved by the
Washington University School of Medicine Animal Studies Committee. Mice were maintained
in a specific-pathogen-free barrier facility. Stomachs from Germline Mist–/– mice and wild-type
C57BL/6 mice of both sexes (Jackson Laboratory), were used at 6 weeks age. Metaplasia was
induced with daily intraperitoneal injection of Tamoxifen (5mg/20g body weight) dissolved in a
vehicle of 10% ethanol and 90% sunflower seed oil (Sigma) as described previously. (Huh et al.,
2012)
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H. Pylori growth and murine infection
H. pylori growth conditions and murine infection. The WT cag+ H. pylori strain, PMSS1,
was cultured on trypticase soy agar with 5% sheep blood agar plates (BD Biosciences). It was
then cultured in Brucella broth (BB, BD Biosciences) supplemented with 10% FBS (Atlanta
Biologicals) for 16 to 18 hours at 37°C with 5%CO2. Male C57BL/6 mice were purchased from
Jackson Laboratories and housed in the Vanderbilt University Animal Care Facilities in a room
with a 12-hour light-dark cycle at 21°C to 22°C. Mice were orogastrically challenged with either
Brucella broth (BB), as an uninfected (UI) control (referred to here as "Mock infected"),or with
the mouse-adapted wild-type cag + H. pylori strain PMSS1. Mice were euthanized at 4 and 8
weeks post challenge and gastric tissue was harvested for immunohistochemistry as described
below.
Patient samples
Examination of human gastric pathological tissue specimens was approved by the
Institutional Review Board of Washington University School of Medicine, the Comité de
Bioetica of Nicaragua for Universidad Nacional Autonoma De Nicaragua-Facultad De Ceincias
Medicas Managua, and the Research Ethics Board Manager for Health Sciences at the University
of Toronto. Serial sections (4–6 μm thick) obtained from paraffin-embedded tissue samples
(H&E and alcian blue–periodic acid–Schiff stains) were reviewed by two pathologists with
expertise in gastrointestinal diseases. Diagnoses and selection of specific regions of transition
among normal stomach and SPEM stomach were performed by a third pathologist.

48

Immunofluorescence
Stomachs were prepared and stained as described previously.(Ramsey et al., 2007)
Stomachs were inflated with 10% formalin fixative and suspended in fixative for 4 hours at room
temp. Tissue was rinsed with 70% EtOH multiple times, arranged in 2% agar in tissue cassettes,
and paraffin processed. Sections (5µm) were deparaffinized and rehydrated, and antigen retrieval
was performed by boiling in Trilogy Buffer (Cell Marquee Corporation). Slides were blocked in
1% BSA, 0.3% Triton X-100 in PBS, then incubated in primary followed by secondary
antibodies and with fluorescently labeled lectin Griffonia simplicifolia-II (neck cell-specific GSII; 1:1,000; Invitrogen). Finally, slides were incubated for 5 min in 1µg/mL bisbenzimide
(Invitrogen) prior to mounting in 1:1 PBS-glycerol. Primary antibodies used for immunostaining
were: mouse anti-CD13 (1:200, Sigma), goat anti-human gastric intrinsic factor (GIF) (1:2,000;
gift of Dr. David Alpers, Washington University), and sheep anti-PGC (1:10,000; Abcam).
Secondary antibodies were AlexaFluor (488, 594)-conjugated anti-mouse or anti-goat (1:500,
Invitrogen)
Single Cell Isolation
Epithelial cells were isolated by methods modified from previously described
work.(Zavros et al., 2000) Stomachs are removed and washed multiple times in PBS.
Forestomach and antrum were excised, and corpus was sliced into ~1mm2 fragments. In some
experiments, tissue was then placed in 50 µm Medicon (Beckman, a chamber designed for
efficient cutting of tissue),

and mechanically dissociated with 2, 30 second pulses in a

Medimachine (Beckman). Tissue was removed from the Medicon and incubated in 10mL HBSS
with 5mM EDTA and 1mM DTT for one hour at 37° with vigorous shaking. Tissue was
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subsequently passed through a 50 µm mesh filter (Partec). Sections of tissue too large to pass
through the filter were placed in 10 mL RPMI 1640 with 5% BSA (Sigma) and 1.5 mg/mL
Dispase II (Stem Cell Technologies) for 1.5 hours at 37° with vigorous shaking and then passed
through 50 µm mesh again. The dissociated cells that passed through the 50 µm mesh at either
stage were then pooled, washed twice with cold PBS, filtered through a 50 µm mesh filter once
more, and stained for Flow cytometry analysis/sorting.
Flow Cytometry Cell Sorting and Analysis
Single cells from the epithelial isolation were counted and suspended in PBS with 1%
BSA and 5mM EDTA at 1 x106 cells/mL. Cells were stained with epithelial cell adhesion
molecule (EpCAM)-Alexa 647 (1:100, Cell signaling), and CD13-FITC (1:200, BD Pharmingen)
(20 minutes, 4°C). EpCAM+ single cells from the ANPEP+ and ANPEP- fractions were sorted
using a MoFlo FACS machine (Dako/Cytomation) or analyzed by FACScan (Becton, Dickinson
and Company). Flow cytometry data were analyzed with FlowJo 7.6 software.

Immunofluorescent characterization of Sorted Cells
EpCAM+ single cells from the ANPEP+ and ANPEP- fractions were plated on slides for
immunofluorescent staining as follows: 1 x105 cells were pipetted into a plastic chamber, and
centrifuged onto a slide using a Cystospin Slide Centrifuge (Cytospin) for 3 minutes at 800 RPM
as previously described.(Pollock et al., 2013) Cells deposited on the slide were fixed with
methanol (-20°C, 10 minutes), rinsed in PBS, and stained as described above. The number of
GIF-positive cells was then quantified by an observer blinded to experimental condition in the
CD13+ and CD13- fractions of cells in 3 separate experiments.
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qRT-PCR and Western Blot
RNA was isolated using RNeasy (Qiagen) per the manufacturer’s protocol. RNA was
treated with DNase I (Invitrogen) and then reverse transcribed using the SuperScript III
(Invitrogen) standard protocol (most cDNA syntheses started with 1 µg of total RNA).
Measurements of cDNA levels were performed by qRT-PCR using a Stratagene (La Jolla, CA)
MX3000P detection system. Absolute QPCR SYBR green mix (Thermo Scientific) fluorescence
was used to quantify relative amplicon amounts of Gif, Atp4a, and 18s.
Cells for western blot analysis were lysed in RIPA buffer. Proteins were quantified by
DC protein assay (Bio-Rad) and then separated on NuPAGE Bis-Tris gels (Invitrogen),
transferred onto Amersham Hybond ECL nitrocellulose (GE Healthcare, Buckinghamshire, UK)
membranes, and detected by Immobilon chemiluminescence (Millipore). Primary antibodies
used were rabbit anti-ANPEP (Sigma) and rabbit anti-α- and β-tubulin (Cell Signaling).
Secondary antibodies were horseradish-peroxidase-conjugated donkey anti-rabbit IgG (Santa
Cruz Biotechnology, Santa Cruz, CA).

Graphing and Statistics
Experiments were performed at least 3 times independently. Values represent mean ±
standard deviation or standard error of mean as indicated. All statistics and graphs were
determined using GraphPad Prism and visualized with Adobe Illustrator. Statistical analysis was
by one- or two-tailed Student’s t test, depending on the hypothesis prior to commencing the
experiment.
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RESULTS
ANPEP is a membrane-associated protein expressed in fully differentiated ZCs.
Given that ZCs have previously been purified by differential centrifugation and not by specific
markers in published reports, and given our aim to develop flow cytometric techniques to isolate
them, we sought to identify a surface marker exclusively expressed in ZCs. We identified
potential ZC-specific markers with a screen using previously obtained microarray data coupled
with gene ontology analysis.(Capoccia et al., 2013) We compared RNA isolated from pit,
parietal, neck, and zymogenic cells previously obtained using Laser-capture microdissection and
measured gene expression changes among these cell populations (Fig. 1A). We first looked for
targets enriched in zymogenic cells vs. other cell types. Then, we sorted for targets associated
with the plasma membrane, determined by gene ontology terms (Fig. 1B). Using this method, we
found a short list of targets potentially expressed on the surface of the ZC that would allow
isolation via flow cytometry.
The ZC in a normal stomach is a terminally differentiated, professional secretory cell
residing in the base of the gastric unit. The ZC may act as a bellwether of damage or disease with
the capacity to undergo SPEM (i.e., to reprogram to re-express progenitor markers and
proliferate to repair damage to the gastric unit). To identify potential surface markers to enable
the isolation of mature, fully-differentiated ZCs, we looked for those surface markers that were
lost during SPEM induced by gastrotoxic doses of intraperitoneal tamoxifen. High dose
tamoxifen causes rapid parietal cell death spurring ZC reprogramming to SPEM.(Huh et al.,
2012) We performed Affymetrix GeneChip microarrays of the body of the stomach 12h after
injection of tamoxifen (5 mg/20 g mouse weight) or vehicle control. As expected, markers of
terminally differentiated parietal cells were rapidly lost upon treatment with tamoxifen,
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consistent with parietal cells beginning to die: e.g. ATPase, H+/K+ exchanging, alpha polypeptide
(Atp4a). A feature of ZCs undergoing SPEM is that, even though they begin to re-express
progenitor markers, they maintain expression of some ZC genes, while turning off expression of
others. One gene whose expression is known to be rapidly extinguished is basic helix-loop-helix
family member a15 (Mist1).(Lennerz et al., 2010) We used this GeneChip screen to determine
which of the potential ZC surface markers followed the Mist1 pattern, indicating loss of
expression in concert with ZC reprogramming. The only ZC specific surface marker (predicted
from the screen in Fig. 1B) that followed that pattern was Anpep (aka CD13, Fig 1C), whereas
the other markers were not changed significantly or actually increased during SPEM. Western
blot of the mouse corpus gastric epithelium showed that ANPEP protein lingered at the 12h time
point after tamoxifen, but the loss of Anpep mRNA did eventually correlate with decreased
protein also by 3 days of daily injections (Fig. 1D). Thus, ANPEP is a surface marker, specific to
ZCs in the normal stomach and lost upon ZC reprogramming in metaplasia.
ANPEP is expressed exclusively in mature zymogenic cells. To confirm that ANPEP
expression is specific to ZCs, we used immunofluorescent staining in mouse and human
stomachs. With confocal microscopy, we observe that ANPEP was expressed in ZCs but not in
ZC-precursor cells (Fig. 2A-C). As neck cells move towards the base of the gastric epithelium,
they transition into zymogenic cells, rapidly losing expression of neck cell markers like trefoil
factor 2 (TFF2) and Griffonia simplicifolia II (GSII), and begin to express ZC markers eg.
Pepsinogen (PGC) and Gastric intrinsic factor (GIF).(Karam and Leblond, 1993a; Ramsey et al.,
2007) ANPEP expression distinctly marks cells expressing mature ZC markers anddoes not
overlap with cells expressing ZC-precursor neck cell markers (Fig. 2C). Thus, ANPEP
specifically identifies mature ZCs in a pattern that indicates expression on both intracellular and
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plasma membranes supporting the possibility that it might be used as a surface marker to isolate
pure ZCs from the gastric epithelium.

MIST1 is not required for ANPEP expression. MIST1 is a transcription factor
responsible for scaling up the ZC secretory apparatus during terminal differentiation of these
cells.(Mills and Taghert, 2012) Like ANPEP, in the stomach MIST1 is expressed exclusively in
mature ZCs, and its expression is rapidly lost as ZCs scale down their secretory apparatus en
route to SPEM.(Lennerz et al., 2010; Nam et al., 2010) Several of MIST1’s transcriptional
targets that help establish and maintain the cellular machinery that governs ZC secretion of
digestive enzymes have been identified.(Capoccia et al., 2013; Tian et al., 2010) To determine if
Anpep expression might be dependent on MIST1, we analyzed Anpep expression in RNA
isolated from ZCs, and their mucous neck cell precursors, laser-capture microdissected from
wild-type (WT) and Mist1–/– stomach bodies.(Capoccia et al., 2013) As expected, Anpep
expression increased ~10-fold in mature ZCs compared to mucous neck cell precursors;
however, this increase occurred in both WT and Mist1–/– mice. Thus, Anpep expression in ZCs
was clearly not dependent on MIST1 (Fig. 3A). Additionally, ANPEP was clearly expressed at
substantial levels in Mist1–/– ZCs and not mucous neck cells, just as occurs in WT (Fig. 3B).
Note the ZC (and therefore the ANPEP-expressing) regions are significantly smaller, as
previously characterized in mice lacking Mist1.(Ramsey et al., 2007)
ANPEP expression is lost in gastric disease. Recent studies have shown expression of
ANPEP is altered during tumorigenesis.(Razvi et al., 2007; Wulfanger et al., 2012) For example,
loss of ANPEP is an adverse prognostic factor in prostate cancer.(Sorensen et al., 2013) Because
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of our data showing loss of ANPEP in ZCs upon induction of gastric metaplasia, we sought to
determine if ANPEP expression was altered in other models of gastric disease. Infection by the
bacterium, Helicobacter pylori (HP), can cause metaplasia in many people and thereby greatly
increase risk for progression to gastric cancer.(Correa and Houghton, 2007) Indeed, the highdose tamoxifen protocol discussed earlier is a rapid, reversible model for the effects of HP
infection.(Huh et al., 2012) In mice, HP causes, over the course of 2-3 months parietal cell
atrophy, and ZC reprogramming into SPEM.(Yoshizawa et al., 2007) In other words, in mice
colonized by HP, ZCs re-express precursor neck cell markers and become proliferative.
Eventually, HP infection causes hyperplasias and dysplasias.(Herrera and Parsonnet, 2009) We
analyzed the base of gastric corpus units in 3 mice infected with a CagA+ strain of Helicobacter
PMSS1 8 weeks after infection. As expected, infection caused parietal cell atrophy and SPEM in
multiple regions throughout most of the corpus, by this timepoint (data not shown, but see
(Capoccia et al., 2013; Khurana et al., 2013) for previous characterization of infections with this
HP strain in these mice). Using immunofluorescent microscopy, we observed that mice
colonized by HP labeled with both the neck cell marker GSII, and the ZC marker GIF in gastric
ZCs that had reprogrammed into a SPEM differentiation state (Fig. 4A). Only cells that had not
yet reprogrammed at this timepoint (i.e., did not label with GSII) retained their ANPEP
expression.
To determine whether ANPEP expression was also lost in human gastric metaplasia, we
looked at ANPEP expression in tissue sections from a database of tissues infected with HP that
show regions of transition between normal and SPEM-type metaplasia that we have previously
described (Capoccia et al., 2013; Khurana et al., 2013; Lennerz et al., 2010). (Fig. 4B) shows a
representative region of transition to SPEM. As in completely normal human stomach, ZCs
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labeled with antibodies against the ZC digestive enzyme pepsinogen (PGC) also labeled with
antibodies against ANPEP (Fig. 4B). However, ZCs transitioning to SPEM, identified by
labeling with both PGC and the mucous neck/precursor marker GSII, lose ANPEP expression
(Fig. 4B). In glands showing complete SPEM, nearly every cell expresses both neck and
zymogenic markers and has undetectable ANPEP. Even in units nearly completely transformed
to SPEM, a rare PGC+/GSII- ZC (e.g, cell marked by arrow, Fig. 4B) will still be identifiable by
its maintained expression of ANPEP.
Disassociation of Gastric Epithelial Cells and Analysis by Flow Cytometry. Because
of strong cell-cell junctions and the high mucus environment of the stomach, gastric epithelial
cells are challenging to dissociate into single-cell populations for isolation by differential
centrifugation or flow/magnet-based sorting. In the past, we have used laser-capture
microdissection to isolate cells from tissue, which has been useful for isolating smaller numbers
of cells to generate RNA that can be amplified for qRT-PCR or microarray analysis (e.g., Fig.
1A,B). Laser-capture purification of cells is restricted to relatively small numbers of cells and is
not the ideal technique for isolating pure populations of cell populations that are intermingled in
tissues with complex organization like the gastric epithelium.(Bredemeyer et al., 2009) However,
to isolate larger numbers of cells for biochemistry or for culture ex vivo in organoids, we
experimented with multiple published protocols and with previous methods for dissociation used
in our lab.(Mills et al., 2003; Mills et al., 2001; Zavros et al., 2000) We found that by
mechanically

disaggregating

epithelial

tissue

before

enzymatic

digestion

using

a

Medimachine,(Ottesen et al., 1996) we were able to reduce the fraction of cell aggregates and
doublets ~5-fold when compared to tissue cut into small pieces with a razor blade before
subsequent enzymatic digestion (Fig. 5A). Mechanical disaggreagation did not affect cell

56

viability as measured by Propidium Iodide incorporation (Fig 5B). We have also found that in
addition to difficulty in achieving single cell dissociation, analysis of gastric epithelial cells with
flow cytometry is complicated by high levels of autofluorescence of gastric epithelial cells.
Dissociated single cells from normal mouse stomach fluoresce across the detectable spectrum in
response to excitation at multiple wavelengths in the absence of any exogenous label. Indeed
when light emitted from an unstained stomach is compared to that of an unstained spleen in (Fig
5C), it is evident that any positive signal from staining with antibody-conjugated fluorophores
could be potentially obscured by non-specific signal from unstained cells.
When we sorted gastric epithelial cells based on their intrinsic autofluorescence and
characterized them thereafter by lineage marker expression, we observed no consistent pattern in
autofluorescence intensity relative to cell lineage or viability (not shown). We established a
method that reliably detects true positive cells with specific staining by first analyzing emission
of a gastric epithelial cell population in two close wavelengths on the same plot as shown (Fig
5D). The autofluorescence in both channels is similar, causing a linear plot of ~x=y light
emission in each channel. When these cells are stained with an antibody conjugated with a fluor
that emits at one of the wavelengths, the additional signal is detectable, so positive cells can be
identified as a population distinct from the autofluorescent cells on the diagonal of the plot. By
looking simultaneously at the detectors for APC (positive channel, stained with APC-conjugated
EpCAM antibody) and APC-Cy7 (negative control channel, used to adjust for autofluroescence)
in (Fig. 5D), we can see that a population of Epithelial Cell Adhesion Molecule (EPCAM)
positive cells is distinguishable. This distinct population would not be readily observable by
analyzing APC signal alone. Mechanical disaggregation and FACS analysis, carefully controlled
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for autofluorescence, allowed for accurate and repeatable analysis of individual populations of
gastric epithelial cells.
ANPEP can be used to isolate mature ZCs from the gastric epithelium. We used the
above method with ANPEP as a surface marker to isolate a purified population of zymogenic
cells (Fig 6A). We dissociated, then stained gastric epithelial cells with an APC-Cy7 conjugated
anti-ANPEP antibody. We found ~14% of EPCAM+ epithelial stomach cells were also ANPEP+,
consistent with the fraction of gastric epithelial cells that are differentiated ZCs.(Mills et al.,
2003) Additionally, flow-sorted ANPEP positive cells expressed the ZC-specific marker GIF
(Fig. 6B,C) but not the parietal cell-specific marker Atp4a, while the ANPEP negative fraction
expressed Atp4a but not GIF (Fig. 6C). We next induced SPEM using tamoxifen, which led, as
expected, to a decreased fraction of ANPEP-positive epithelial cells, consistent with earlier
findings in tissue (Fig. 6D).
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Discussion
Elucidation of the molecular mechanisms regulating normal homeostasis in the stomach
as well as aberrant differentiation patterns like SPEM has been hindered by a limited toolkit for
isolating and studying individual cell populations. There are few markers of mature gastric ZCs,
and to our knowledge no ZC-specific surface marker has ever been characterized. Our data show
that ANPEP is expressed exclusively in mature ZCs and that its expression is lost when they
reprogram to SPEM-type metaplastic cells in both mice and humans. Here, we have also
presented what has proven to be a useful for protocol for cell dissociation and flow cytometric
sorting using ANPEP as a marker to purify ZCs. ANPEP-mediated isolation of ZCs can be used
in “OMICS” studies in the future to determine, for example, ZC-specific gene expression,
chromatin modifications, transcription factor binding sites under different conditions.
Alternatively, we have shown that ZCs expressing specific promoters can serve as
stem/progenitor cells ex vivo in organoid systems.(Stange et al., 2013) A method for isolating all
ZCs that is not genetically based (i.e., not based on transgenic or knockin expression of inducible
Cre recombinases) would be useful in determining the progenitor properties of ZCs in a parallel,
complimentary manner.
ANPEP is an integral membrane protein that hydrolyzes peptides in multiple tissues and
has varying functions that depend on the cells and tissues where it is expressed. In the small
intestine, ANPEP hydrolyzes peptides from proteins partially digested by gastric and pancreatic
proteases;(Kruse et al., 1988) it is also required for normal cholesterol absorption. In endothelial
cells, ANPEP is required for cell motility and adhesion, and disruption prevents endothelial cell
invasion in matrigel assays.(Ghosh et al., 2014; Mina-Osorio et al., 2008; Petrovic et al., 2007)
ANPEP null mice don’t manifest any observable phenotypes in normal conditions, but have
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exhibit impaired angiogenesis in pathological settings.(Rangel et al., 2007) We used several
small

molecule

inhibitors

of

CD13

function

(Ezetimibide,

Bestatin,

Tosedostat,

Circumin),(Kramer et al., 2005; Rich et al., 1984; Shim et al., 2003; Wickstrom et al., 2011) but
found no observable phenotype in the normal gastric epithelium (data not shown). ANPEP
expression correlates negatively with progression to prostate cancer and with aggressiveness of
disease.(Sorensen et al., 2013) Expression of ANPEP is also known as myeloid antigen, because
it is expressed in myeloid lineages of the bone marrow, and has been proposed to correlate with
worse prognosis in lymphoblastic leukemias.(Craddock et al., 2013; Dalal et al., 2014; Shim et
al., 2014) Despite a large, and somewhat controversial literature on the topic, it is not clear there
is functional significance for ANPEP expression in lymphoid leukemias; it may simply be a
reflection of abnormal gene expression as a whole where genes normally restricted to the
myeloid lineage are mis-expressed in lymphoid neoplasms.(Alfalah et al., 2006; Pasqualini et al.,
2000; Saxena et al., 2010) ANPEP expression has been shown to be increased in gastric cancers
with poor prognosis, though we are unaware of previous reports on its expression in normal
fundic-type mucosal cells like ZCs.(Carl-McGrath et al., 2004) Given that ANPEP is a known
intestinal protein, and gastric cancers frequently have intestinal differentiation,(El-Zimaity et al.,
2002; Hattori, 1986) it is possible that ANPEP expression is correlated with progression from
SPEM (thought to be the earliest lesion in gastric cancer tumorigenesis as it correlates with loss
of parietal cells in the stage known as Atrophic Gastritis),(Nozaki et al., 2008) in which ANPEP
is not expressed as we show in the current study, to later stage disease like intestinal metaplasia,
dysplasia, and cancer where it returns.
The role of ANPEP is in ZCs is not clear. Its rapid loss during SPEM in multiple mouse
models and human tissue indicates that it may play a role in their secretory function, as one of
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the first events in ZC reprogramming during injury is scaling down MIST1 and the secretory
apparatus.(Lennerz et al., 2010) ANPEP expression is on the plasma membrane and also seems
to be distributed around secretory granules in ZCs. It has been shown to help regulate
phagocytosis,(Villasenor-Cardoso et al., 2013) be required for development of secretory tissue
like mammary glands(Kolb et al., 2013) and for secretion of cytokines.(Kuhlmann et al., 2009)
An interesting function of ANPEP seems to be to specifically degrade the cytokine like IL-8.
(Kanayama et al., 1995; Mishima et al., 2002) Perhaps ZC ANPEP helps reduce IL-8 abundance
under homeostatic conditions. More severe damage that can lead to reprogramming of ZCs and
loss of ANPEP would allow increased abundance of this cytokine to the gastric epithelium.
In summary, we have refined protocols for the isolation, and analysis of gastric epithelial
cells have identified the first surface marker of mature ZCs useful for flow cytometry, and have
described the pattern of this protein ANPEP in normal and metaplastic gastric epithelium. The
tools should allow for additional characterization of other isolated gastric epithelial cells with
other markers and help us better understand the biology of the elaborate but highly plastic
digestive-enzyme secreting cells of the stomach.
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Figure Legends:
Figure 1. ANPEP is expressed in mature gastric zymogenic cells. A) H&E stained gastric unit.
Each circle represents a distinct cell lineage isolated for Microarray analysis. B) Heat map
representing enrichment of surface markers of ZCs. Genes enriched in ZCs when compared to
other cell populations were sorted by gene ontology terms for plasma membrane markers. 5
potential candidates were identified. C) Change in candidate gene expression in response to
tamoxifen-induced metaplasia, measured by microarray of RNA isolated from corpus portion of
mouse stomach. MIST1 is known to be lost in metaplasia. ANPEP was the only candidate from
panel B with decreased expression. D) Western blot of mouse stomach. ANPEP expression is
lost when metaplasia is induced with tamoxifen, though loss of protein trails loss of mRNA
expression in panel C

Figure 2. ANPEP is expressed exclusively in zymogenic cells. A,B) Human and mouse gastric
epithelium respectively stained with ANPEP (green), neck cell specific GSII (purple), and
zymogenic cell specific PGC (red). In every mature zymogenic cell, PGC and ANPEP are
expressed, but not GSII. C) Confocal image of ZC region of mouse gastric epithelium stained as
described above. ANPEP expression is absent in cells that express GSII. Arrowhead marks a cell
in transition between neck and ZC zones. ANPEP is not expressed where GSII epitope is
maintained and marks only cells that express the ZC marker GIF (Gastric Intrinsic Factor, red).
All scale bars represent 20μm

Figure 3. MIST1 is not required for Anpep expression. A) Affymetrix GeneChips generated
from lasercapture microdissected ZCs and their precursor mucous neck cells from wild-type and
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Mist1 null mice. Mist1 and Anpep gene expression are enriched in the ZCs relative to neck cells.
Anpep expression is not decreased when Mist1 is deleted. B) Immunofluorescent staining of wild
type and MIST1 KO mouse stomach showing no loss of ANPEP protein in ZCs despite the
absence of MIST1. Note loss of MIST1 does make ZCs smaller.

Figure 4. ANPEP is lost during ZC metaplasia. A) ZCs in mouse stomachs infected with H.
pylori undergo SPEM, evidenced by overlapping PGC and GSII expression in the base of units.
SPEM cells that express both GSII and PGC do not express ANPEP (yellow arrowhead) B)
Tissue from a patient infected with H. pylori in a region of transition between normal basal
gastric gland architecture and SPEM-type metaplastic differentiation pattern, ANPEP is
expressed only in mature ZCs; i.e., only in cells expressing the digestive enzyme PGC and not
the SPEM/mucous neck cell marker GSII. Normal tissue, tissue transitioning to SPEM, and
SPEM tissue is highlighted from left to right, respectively. Asterisk indicates a cell that expresses
both neck and ZC markers (i.e. a SPEM cell), but not ANPEP, adjacent to a cell that expresses
only ZC markers and has not lost ANPEP expression (i.e. a normal ZC). White arrowhead
denotes the only cell in the SPEM unit that expresses only ZC markers and retains ANPEP
expression.

Figure 5. Optimization of FACS to sort and analyze gastric epithelium A) Doublet
discrimination analysis of mouse gastric epithelium shows mechanical disaggreagation is
necessary to achieve single cell isolation (Mean±SEM, n=3 biological replicates). B) Additional
mechanical disaggreagation does not increase cell death in mouse gastric epithelial cells.
(Mean±SEM, n=3 biological replicates). C.) Autofluorescent histograms of unstained spleen
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(grey) and stomach (red) throughout detectable fluorescent spectrum. High levels of
autofluorescence are present throughout the spectrum in gastric epithelial cells. D) EpCAM
staining of single gastric cells.

Figure 6. ANPEP can be used to isolate ZCs A) FACS plot of ANPEP stained gastric
epithelium. EpCAM-positive cells were stained with an APC-Cy7 conjugated ANPEP antibody
(x-axis) and plotted against autofluorescence in an unstained channel (APC) B) quantification of
ZC marker positive cells in sorted fractions. ANPEP-positive mouse gastric epithelial cells were
isolated using flow cytometry, and attached to a slide using cytospin. Cells were then stained for
the ZC marker GIF, and quantified. (Mean±SEM, n=3 biological replicates) C) Semi-qPCR of
ANPEP-positive and negative mouse gastric epithelial cell fractions for ZC (Gif) and parietal cell
(Atp4a) specific genes. D) FACS quantification of ANPEP expression in EpCAM-positive
gastric epithelial cells treated with vehicle or high-dose tamoxifen for 12 hours or 3 days to
induce SPEM. (Mean±SEM, n=3 biological replicates)
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CHAPTER FOUR
Transcriptional Regulation of Xbp1 by
HNF4α is Vital to Beta-Cell Function
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Abstract
The transcription factor, X-box Binding Protein-One (XBP1), controls the development
and maintenance of the endoplasmic reticulum (ER) in multiple secretory cell lineages. We
show here that Hepatocyte Nuclear Factor 4-alpha (HNF4α) directly induces XBP1 expression.
Mutations in HNF4α cause Mature-Onset Diabetes of the Young I (MODYI), a subset of
diabetes characterized by diminished glucose-stimulated insulin secretion (GSIS). In mouse
models, cell lines, and ex vivo islets, using dominant negative and human-disease-allele point
mutants or knockout and knockdown models, we show that disruption of HNF4α caused
decreased expression of XBP1 and reduced cellular ER networks. GSIS depends on ER Ca2+
signaling; we show that diminished XBP1 and/or HNF4α in β-cells led to impaired ER Ca2+
homeostasis. Restoring XBP1 expression in the absence of HNF4α was sufficient to completely
rescue GSIS in β-cells. Our findings uncover a transcriptional relationship between HNF4α and
Xbp1 with potentially broader implications about MODYI and the importance of transcription
factor signaling in the regulation of secretion.

Summary
HNF4α transcriptionally regulates XBP1, and loss of HNF4α causes diminished
pancreatic β cell insulin secretion that is rescued by XBP1.
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Introduction
Cells use transcription factors to regulate expression of gene cohorts that coordinate
response to stress, determine specific developmental fates, and scale intracellular architecture
during physiology and disease.(Huh et al., 2010; Mills and Taghert, 2012). It is well established
that ER stress causes increased activity of the transcription factor x-box binding protein 1
(XBP1) via IRE1 splicing of the XBP1 transcript.(Shen et al., 2001; Yoshida et al., 2001).
However, XBP1 also establishes the subcellular machinery for synthesizing large quantities of
protein during the normal development of professional secretory cells.(Huh et al., 2010; Lee et
al., 2005). How XBP1 is induced during differentiation of secretory cells even in the absence of
substantial ER stress is unclear, but an obvious mechanism is that XBP1 may also be
transcriptionally regulated. Hepatocyte Nuclear Factor 4-alpha (HNF4α) is a highly-conserved
transcription factor responsible for orchestrating the early development and maintenance of
multiple adult organs. As a master developmental regulator, HNF4α likely acts upstream of the
factors that establish the extensive cellular machinery required in professional secretory cell
lineages within those organs. Despite overlapping expression and function, no direct relationship
between HNF4α and XBP1 has yet been described.
HNF4α is vital for β-cell function, and indeed, human mutations in HNF4α cause
Mature-Onset Diabetes of the Young 1 (MODYI), a subset of diabetes characterized by
diminished glucose-stimulated insulin secretion (GSIS) in pancreatic β-cells.(Yamagata et al.,
1996) While we know that β-cells require HNF4α to function, we understand little about the
mechanistic/physiological role of HNF4α in these cells. Previous work showed that disrupting
HNF4α expression in vivo in mouse islets resulted in diminished GSIS similar to that observed
in MODY patients with HNF4α mutations. Loss of HNF4α also was observed to disrupt Ca2+
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signaling, though the mechanisms underlying those defects remain unclear. Decreased ER
function is a plausible mechanism for the loss of function in MODYI β-cells, because: insulin
secretion in β-cells is diminished if ER homeostasis is disturbed, (Cardozo et al., 2005; Hara et
al., 2014) defects in ER-related proteins contribute to multiple diabetic phenotypes in
humans,(Inoue et al., 1998) and HNF4α has been shown to be important for maintaining ER
stress response.(Luebke-Wheeler et al., 2008) In addition, knocking down XBP1 specifically in
β-cells also leads to significantly reduced GSIS. Finally, disruption of calcium homeostasis in
the ER leads to impaired GSIS, similar to the pathology observed in MODY1 islets.(Jacobo et
al., 2009)
Here we have identified how XBP1 expression is governed at the transcriptional level
and establish HNF4α as a direct transcriptional regulator of its expression. This implicates
HNF4α in the maintenance and establishment of secretory-cell ER networks. Accordingly, we
report for the first time that both HNF4α and XBP1 are required to maintain ER calcium
homeostasis and GSIS in β-cells. In addition, we show that restoration of XBP1 expression alone
in islets lacking HNF4α is sufficient to rescue impaired GSIS. Thus, the results may provide new
insight towards discerning why dysfunction in HNF4α causes the pathophysiological findings in
MODYI patients.
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Results
Regulation of Xbp1 by HNF4α. To elucidate the potential transcriptional regulation of
XBP1, we identified evolutionarily conserved binding sites in the human XBP1 promoter by
aligning regions of synteny, then screening them with the Transfac transcription factor binding
site database.(Ovcharenko et al., 2005) Two regions with high conservation containing putative
HNF4α binding sites, 1.4 and 2.6 kilobases upstream of the Xbp1 transcription start site, were
identified using first the Transfac transcription factor binding library and then affirmed using a
previously published algorithm developed to search for sites of high HNF4α binding
affinity.(Bolotin et al., 2010) These putative binding sites were constitutively occupied by
HNF4α in mouse pancreas, measured via chromatin immunoprecipitation (Fig. 1A).
Overexpression and knockdown experiments in vitro showed HNF4α was both sufficient and
necessary for normal Xbp1 expression in pancreatic β-cell derived-cell lines. Disrupting HNF4α
either by siRNA knockdown (Fig. 1B,C) or by overexpressing a dominant-negative version of
HNF4α (Fig. 1D,E) resulted in a 65-75% decrease in Xbp1 expression in INS-1 and MIN-6 cells.
Conversely, overexpression of HNF4α via transient transfection caused a five-fold increase in
Xbp1 expression (Fig. 1F). To further substantiate this transcriptional relationship, we analyzed
the effects of Hnf4α deletion on Xbp1 expression in other tissues by mining published microarray
studies and by direct qRT-PCR analysis of adult and embryonic liver(Battle et al., 2006) as well
as adult small intestine (Supplemental Fig. 1)(Bonzo et al., 2012; Cattin et al., 2009; Hayhurst et
al., 2001). Again, the results showed a consistent trend toward correlation of Xbp1 expression
decrease with loss of Hnf4α in multiple secretory tissues.
Various single point mutations in the HNF4α locus have been identified in patients
afflicted with MODYI. To better understand the impact of these mutations, we designed two
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HNF4α expression vectors, each containing one of the most prevalent MODYI mutations.(Furuta
et al., 1997; Lindner et al., 1997) Each of these mutations expressed both a fully functional
homo-dimerization domain and DNA-binding domain but an altered or truncated ligand-binding
domain (Supplemental Fig. 2A,B). Overexpression of each of these individual MODYI mutants
in INS-1 cells resulted in a ~4-fold decrease in the expression of XBP1 (Supplemental Fig. 2C),
suggesting that prevalent MODYI mutations decrease XBP1 expression in vitro.

HNF4α is required for ER maintenance in vivo. The mechanisms whereby disruptions
of HNF4α in MODYI cause β-cell dysfunction remain an area of open debate. As XBP1 is
critical in scaling up and maintaining the ER of professional secretory cells, we hypothesized
mutations in HNF4α may drive MODYI pathology via dysregulation of XBP1 and consequent
ER dysfunction in the insulin-secreting β-cells. We also sought to study the relationship between
HNF4α and XBP1 in vivo in mice with loss of Hnf4α induced in adulthood, mirroring the onset
of MODYI. After global deletion of Hnf4α in adult mice, we observed significant loss (~60%) of
Xbp1 expression in islets and of XBP1 transcriptional targets like Edem1 (Fig. 2A) when
compared to littermate Hnf4αfloxed/+controls (referred to hereafter as “WT”) (Lee et al., 2003).
Supporting previous findings, Insulin and Hnf1α mRNA levels were unaffected by loss of
Hnf4α.(Gupta et al., 2005; Miura et al., 2006) In accordance with XBP1’s role in professional
secretory cells of maintaining cell architecture and not as a predominantly ER-stress-response
gene (Huh et al., 2010; Todd et al., 2009), decreased XBP1 in Hnf4αΔ/Δ mice did not cause
increase in the unfolded-protein response genes Chop, Bip, or Atf4, nor a decrease in mRNA
levels of the ER marking Calregulin (CRP55) (Fig. 2B). However, loss of XBP1 following
deletion of Hnf4α did correlate with a nearly 7-fold reduction in ER network in β islet cells (Fig.
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2C,D, Supplemental Fig. 3A-D). Despite decreased ER in each cell, islet area was not changed in
Hnf4αΔ/Δ pancreata (Fig. 2E), indicating that Hnf4α is not required to maintain islet number or
size. Thus, loss of Hnf4α caused diminished ER network, a phenotype similar to that caused by
deleting Xbp1 from existing adult secretory cells.(Huh et al., 2010; Lee et al., 2005)

HNF4α and XBP1 are necessary to maintain ER calcium homeostasis. In previous
reports, constitutive deletion of Hnf4α from islets early in development, as opposed to in the
adult, caused impaired GSIS.(Gupta et al., 2005; Miura et al., 2006). The mechanism of
decreased GSIS was hypothesized to result from dysregulated cytoplasmic Ca2+ signaling in
response to glucose, but the molecular mechanism driving this impairment has remained unclear.
Ca2+ signaling depends on the ATP-dependent closure of KATP channels, triggering membrane
depolarization and opening voltage-gated Ca2+ channels(Ashcroft et al., 1984). Thus, one
mechanism that could mediate how loss of Hnf4α could cause GSIS could be via disruption of
those channels. However, qPCR analysis showed levels of the KATP channel subunits Sur1
(Abbc8) and Kir6.2 (Kcnj11) in Hnf4αΔ/Δ islets were unchanged relative to littermate controls
(Fig. 3A). The sulfonylurea Tolbutamide, which closes KATP channels leading to membrane
depolarization, stimulated less insulin secretion in INS-1 cells expressing dnHNF4α than in
normal INS-1 cells (Supplemental Fig. 4). The inhibition of Tolbutamide-stimulated insulin
secretion caused by disrupted HNF4α was rescued by transduction of Xbp1, though transducing
Xbp1 alone did not increase tolbutamide-stimulated insulin secretion (Supplemental Fig. 4).
These data, along with previous work showing impaired insulin secretion even upon
depolarization with KCl,(Gupta et al., 2005) suggest the defect in the glucose response pathway
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due to disrupted HNF4α is distal to KATP channel dependent-membrane depolarization and
depends on loss of XBP1.
Though KATP channel expression was unchanged in Hnf4αΔ/Δ islets, expression of the
putative XBP1 transcriptional target, Serca2b(Atp2a2), was significantly reduced. (Park et al.,
2010) SERCA2b is an ER Ca2+ pump, responsible for establishing and maintaining the large
calcium gradient between the ER and cytoplasm.(Vangheluwe et al., 2005). , Intracellular stores
of Ca2+ are critical for GSIS, because Ca2+ release from these stores triggers secretion of insulin
granules. Accordingly, decreasing ER Ca2+ stores and/or flux has been shown to disrupt GSIS
(Jacobo et al., 2009). Thus, in Hnf4αΔ/Δ mice, the decreased expression of a key molecular driver
of the ER Ca2+ gradient suggested that disruption of ER Ca2+ stores may play a critical role in the
GSIS abnormalities seen in the absence of normal HNF4α. We used an ER-specific FRET sensor
to measure ER [Ca2+] in ΔHnf4α β-cells (Hara et al., 2014; Palmer et al., 2004). The D1ER
cameleon construct encodes two fluorophores conjugated to a calmodulin molecule that is
targeted specifically to the ER lumen with a KDEL sequence. When it binds Ca2+, the cameleon
undergoes a conformational change that approximates the fluors to produce FRET activity
quantitatively proportional to ER [Ca2+] (Fig. 3B). In accordance with the mechanism of lost
GSIS in MODYI being disruption of XBP1-mediated ER Ca2+ stores, both knockdown of
HNF4α and pharmacological inhibition of XBP1 activation in INS-1 cells resulted in decreased
ER [Ca2+] (Fig. 3C). Simultaneously knocking down HNF4α and pharmacologically inhibiting
XBP1 did not augment the decreased ER [Ca2+]. Thus, it is likely that HNF4α and XBP1 work
via the same pathway to maintain high ER [Ca2+] in adult β-cells. To further explore the
requirement of HNF4α for proper Ca2+ signaling in β-cells, we observed changes in cytoplasmic
Ca2+ levels in response to various stimuli in ΔHnf4α and normal INS-1 cells using Fura 2AM-
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based Ca2+ imaging. Expectedly, ΔHnf4α β-cells exhibited a diminished response to stimulation
with 16.7mM glucose, as observed in other MODYI β-cell models (Fig. 3D, Supplemental Fig.
5A). To identify the cause of this deficit in Ca2+ signaling, and further explore our previous
results indicating HNF4α is required for ER Ca2+ homeostasis, we exposed these cells to 20mM
Caffeine. Caffeine is an agonist of the ryanodine receptor that stimulates release of Ca2+ from
stores in the ER and thus an increase in cytoplasmic [Ca2+].(Verkhratsky and Shmigol, 1996)
Caffeine induced diminished cytoplasmic [Ca2+] increase in ΔHnf4α β-cells (Fig. 3E,
Supplemental Fig. 5B), indicating that ER Ca2+ homeostasis is disrupted. In short, loss of ER
Ca2+ in ΔHnf4α β-cells may underlie their impaired GSIS.

XBP1 is sufficient to rescue insulin secretion in ΔHnf4α β-cells. We next sought to
confirm the physiological relevance of the HNF4α→XBP1 relationship by determining if we
could rescue aberrant GSIS in the absence of HNF4α simply by restoring XBP1. If XBP1 were
decreased in the absence of HNF4α due to direct loss of transcriptional upregulation by HNF4α,
as we hypothesized, then restoration specifically of unspliced XBP1 (XBP1u) should rescue
GSIS, because XBP1u is the unmodified mRNA directly generated from transcription of the
XBP1 gene. We used an in vitro model employing transgenic INS-1 cells containing a
doxycycline inducible dominant negative-HNF4α (dnHNF4α ) (Wang et al., 2000). As with
other methods we used to examine how loss of HNF4α activity affected insulin-secreting cells
(e.g., Fig. 1D), doxycycline treatment to induce dnHNF4α caused both decreased XBP1 and loss
of GSIS (Fig. 4A). This decreased GSIS was completely rescued by adenoviral transduction of
Xbp1u. As discussed above, forced expression of Xbp1u was also sufficient to rescue impaired
insulin secretion in response to sulfonylurea treatment in these dnHNF4α β-cells (Supplemental
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Fig. 4). We repeated this study ex vivo, using Hnf4αΔ/Δ islets isolated 3 weeks following
tamoxifen-induced Hnf4αΔ/Δ deletion. As expected, cultured islets had impaired GSIS due to
HNF4α deficiency. Xbp1u restoration increased the direct XBP1 transcriptional targets Edem1
and Serca2b (Fig. 4B) confirming that transduction of Xbp1u restored functional XBP1-mediated
transcriptional activity to scale up expression of its normal transcriptional targets. Remarkably,
restoring unspliced Xbp1 expression in these ex vivo cultured, HNF4α-deficient β-cells was also
sufficient to completely rescue their GSIS, indicating that the impaired GSIS in the absence of
HNF4α depends on transcriptional maintenance of XBP1 expression by HNF4α (Fig. 4C).
Because of the direct transcriptional regulation of XBP1 by HNF4α and the lack of GSIS
enhancement in WT β-cells transduced with Xbp1u, the ability of Xbp1u to rescue the phenotype
caused by loss of HNF4α is likely because it corrects the diminished basal Xbp1 expression in
ΔHNF4α β-cells.
We also transduced spliced XBP1 (Xbp1s) in isolated ΔHNF4α mouse islets, bypassing
the normal regulation of transcriptionally regulated Xbp1u by IRE1α splicing. Transduction of
Xbp1s rescued the XBP1 targets, Edem1 and Serca2b (Supplemental Fig 6A) but resulted in
GSIS roughly 50% lower than that in control WT islets (Supplemental Fig 6B). That result is
consistent with previous reports that β-cell homeostasis is compromised by forced expression of
spliced Xbp1 because cells must be able to dynamically regulate XBP1 levels via the endogenous
IRE1 splicing mechanism (Allagnat et al., 2010). Accordingly, Hnf4α

Δ/Δ

islets infected with

Xbp1s exhibited GSIS rescue to the levels observed in WT islets infected with Xbp1s, suggesting
that, while forced expression of XBP1s is detrimental to β-cell health, it is still able to
compensate for GSIS defects in β-cellscaused by the absence of HNF4α.
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Discussion
We report that Xbp1 is a direct transcriptional target of HNF4α in multiple secretory
tissues. Given the importance of HNF4α mutations in diabetes, we have focused on the
relationship between HNF4α and XBP1 specifically in insulin-secreting β-cells. Deletion of
HNF4α in β-cells causes them to lose XBP1, which in turn causes dismantling of ER. HNF4α
point mutants designed to match mutations that cause human MODYI also resulted in loss of
XBP1 in vitro. Loss of either HNF4α or XBP1 leads to disrupted ER Ca2+, which in turn
diminishes GSIS, a pathology that can be completely rescued by reestablishing normal XBP1
levels (Fig 4D, Supplemental Fig. 4,6). Together, our results identify a new transcriptional
relationship between evolutionarily-conserved genes, Xbp1 and Hnf4αΔ/Δ, involved in
fundamental development and disease in multiple tissues.
We also demonstrate specific cellular contexts during which Xbp1 expression is
functionally regulated at the transcriptional level. XBP1 is induced in response to unfolded
protein accumulation in the ER by splicing of its message via the endonuclease IRE1α, and the
canonical view of how XBP1 abundance is modulated concern that mechanism. On the other
hand, in multiple, long-lived professional secretory cells like antibody-secreting plasma cells and
zymogenic chief cells, expression of the unspliced Xbp1 transcript also increases many fold.(Huh
et al., 2010; Reimold et al., 2001) Thus, there are likely transcriptional mechanisms that govern
expression of Xbp1 as well, though these have largely not been elucidated. It is somewhat
surprising that HNF4α, which is largely studied in developmental contexts as a master regulator
of differentiation in endodermal organs, is required for continued maintenance of XBP1 in
differentiated, adult cells. However, unbiased, comprehensive screens for genes whose
expression depends on HNF4α have previously identified XBP1 as a potential target(14-17), and
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chromatin immunoprecipitation followed by sequencing (ChIP-Seq) has also shown peaks
indicating potential binding of HNF4α to the putative XBP1 promoter.(Boyd et al., 2009) Thus,
though the results of the previous screens have not been validated and the direct relationship
between HNF4α and XBP1 has apparently never been specifically studied, our results are not
entirely unprecedented. Indeed, HNF4α has also been shown to regulate expression of ankyrin
repeat and sterile α motif domain containing 4b (Anks4b), a protein that binds ER chaperones
and augments the ER stress response, supporting our hypothesis that HNF4α is required for the
establishment and maintenance of the ER.(Sato et al., 2012)
ER Ca2+ homeostasis is important for myriad cellular processes and plays a pivotal role in
intracellular Ca2+ signaling. Our data indicate that XBP1 and HNF4α are required for
maintaining this homeostasis. The targets whose expression is dictated by XBP1/HNF4α and
help maintain ER homeostasis are not clear, but one such candidate target may be SERCA2b.
Transduction of XBP1u or XBP1s in β-cells increased expression of SERCA2b, the ER Ca2+
transporter, in isolated islets (Fig. 4B, Supplemental Fig. 6A), confirming previous studies
performed in vivo in the liver.(Park et al., 2010) Thus, our results indicate that knocking down
HNF4α causes disruption of the expression of the Ca2+ pump responsible for establishing the
high [Ca2+] in the ER, a functional decrease in ER [Ca2+], and finally, a diminished release of ER
Ca2+ when cells are stimulated with caffeine (Fig. 3A,C,E). These data outline a potential
mechanism wherein altered ER Ca2+ homeostasis from loss of HNF4α function disrupts Ca2+
signaling and insulin release in β-cells of patients with MODYI (model in Supplemental Fig. 7).
There are no faithful animal models of MODYI. Some mutations in HNF4α in humans
result in alleles though to cause diabetes via a dominant negative mechanism,(Furuta et al., 1997;
Lindner et al., 1997) whereas others would be expected to act via haploinsufficiency.(Alam et
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al., 1995; Thomas et al., 2001) Thus, it may be premature to reach any firm conclusions about
MODYI mechanisms based on our results using known MODYI-inducing human
polymorphisms and adult-onset knockout of Hnf4α in mice. However, if we are to speculate on
the implications of our findings, we might suggest that they indicate consideration of a new angle
on MODYI therapy. Currently, MODYI is responsive to treatment with sulfonylureas, though
treatment often

eventually involves insulin therapy to manage hyperglycemia, presumably

because β-cells eventually become dysfunctional or die (Pearson et al., 2005). Our results
suggest that various therapies targeting ER homeostasis, a rapidly developing therapeutic avenue
with several drugs at various stages of development, may augment or improve existing
approaches to managing MODYI.
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Materials & Methods
Cell lines and Transient Transfection
Min6 cells were routinely maintained in Dulbecco’s modified Eagle’s medium (DMEM)
containing 25 mM glucose, supplemented with 10% fetal calf serum, 2 mM L-glutamine, 25 mM
Hepes, and 285 µM 2-mercaptoethanol, and penicillin and streptomycin. INS-1 832/13 cells
were cultured in the RPMI 1640 containing 10% fetal bovine serum (FBS), penicillin and
streptomycin, sodium pyruvate and β-mercaptoethanol. Human embryonic kidney (HEK)-293
cells (ATCC) were cultured in DMEM containing 10% FBS and penicillin and streptomycin.
INS-1 cells containing doxycycline inducible dnHNF4α were treated with 500ng/mL
doxycycline to induce expression as previously described.(Wang et al., 2000) All cells were
passaged at 90% confluency using trypsin-EDTA. For overexpression of myc-tagged HNF4α2
coding regions (obtained from addgene) were subcloned into a pcDNA3.1expression vector, and
5μg of each plasmid or the pmaxGFP(lonza) control plasmid were transiently transfected using
TransIT-2020 (Mirus, Madison, WI). For mutation analysis, site-directed mutagenesis was
performed using the HNF4α overexpression vector described above as an initial template.
Mutations were introduced for each mutant using primers listed in (Supplemental Fig. 9).
Constructs were verified to be correct by DNA sequencing. For siRNA we transfected MIN6 and
INS-1 cells with 10nM HNF4α siRNA (silencer select Invitrogen) using Lipofectamine 2000
according to the manufacturer’s protocol.
in silico Identification of HNF4α binding sites in XBP1 promoter
Areas of high conservation among multiple mammalian species (human, rhesus, mouse,
rat, dog) 10kb upstream and downstream of the XBP1 transcription start site were identified
using ECR browser (http://ecrbrowser.dcode.org/). These areas were then scanned with the
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Transfac transcription factor binding database for known transcription factor binding site
sequences. Two Hnf4α sequences were identified; one 1.2 kb upstream (hg19 chr22:29,198,941)
of the Xbp1 transcription start site and one 2.4 kb upstream (hg19 chr22:29,197,731).
qRT-PCR and Western Blot
RNA was isolated using RNeasy (Qiagen) per the manufacturer’s protocol. RNA was
treated with DNase I (Invitrogen) and then reverse transcribed using the SuperScript III
(Invitrogen) standard protocol (most cDNA syntheses started with 1 µg of total RNA).
Measurements of cDNA levels were performed by qRT-PCR using a Stratagene (La Jolla, CA)
MX3000P detection system. Absolute QPCR SYBR green mix (Thermo Scientific) fluorescence
was used to quantify relative amplicon amounts of Primers listed in Supplemental Fig. 9.
Cells for western blot analysis were lysed in RIPA buffer. Proteins were quantified by
DC protein assay (Bio-Rad) and then separated on NuPAGE Bis-Tris gels (Invitrogen),
transferred onto Amersham Hybond ECL nitrocellulose (GE Healthcare, Buckinghamshire, UK)
membranes, and detected by Immobilon chemiluminescence (Millipore). Primary antibodies
used were rabbit anti-XBP1(Santa Cruz), mouse anti-c-myc (dshb), and rabbit anti-α- and βtubulin (Cell Signaling). Secondary antibodies were horseradish-peroxidase-conjugated donkey
anti-rabbit and anti-mouse Ig (Santa Cruz Biotechnology, Santa Cruz, CA). Quantifications of
immunoblots were performed by scanning 16-bit images into ImageJ. Band intensities for XBP1
and α/β tubulin were selected and calculated by using the ‘Analyze mean gray value’
measurement tool. Standardized values were calculated determining the ratio of XBP1 signal to
α/β tubulin signal.
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Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as described previously.(Im et al.,
2004) Approximately 100 mg of tissue from the pancreata of 5, 6-8 week old WT mice were
homogenized and used for this ChIP experiment. Ten microliters of anti-HNF4α (rabbit antihuman MIST1) or whole rabbit serum (preimmune control) together with protein A/G plus
agarose (Santa Cruz Biotechnology, Santa Cruz, CA) was added to the homogenized tissue for
immunoprecipitation. Quantitative real-time PCR (qRT-PCR) was performed (the sequences
used and all other primer sequences are available in Supplemental Fig. 9) to assess the quantity
of genomic sequences immunoprecipitated by either preimmune control or HNF4α antiserum, as
well as a 1:10 dilution of the cell extract prior to immunoprecipitation (input). Two predicted
HNF4α binding sites were probed in addition to an intronic control region with no predicted
HNF4α binding sites nearby. Data are graphed as a percentage of precipitated DNA:total
input(genomic DNA).

Mouse Studies
All experiments involving animals were performed according to protocols approved by
the Washington University School of Medicine Animal Studies Committee. Floxed HNF4α,
CAGGCreERTM transgenic mice were generated by crossing Hnf4αfloxed/floxed mice (a gift from
Frank Gonzalez, NIH)(Hayhurst et al., 2001) with CAGGCreERTM;Hnf4αfloxed/+(Hayashi and
McMahon, 2002) mice to allow systemic, tamoxifen-inducible knock out of HNF4α. 6-8 week
old CAGGCreERTM;Hnf4αfloxed/floxed mice and CAGGCreERTM;Hnf4αfloxed/+ littermate controls
were injected intraperitoneally with tamoxifen (5mg/20g body weight, 5 consecutive days) to
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induce cre-mediated Hnf4α deletion. Mice were sacrificed 4 weeks after first tamoxifen
injection. No mouse samples were excluded from analysis in this study.

Beta-cell morphological characterization using Immunofluorescence
Pancreata were prepared and stained as described previously.(Tian et al., 2010) Briefly,
they were fixed with freshly prepared formalin and suspended in fixative for 24 hours at room
temperature, followed by multiple rinses in 70% ethyl alcohol (EtOH), arrangement in 2% agar
in a tissue cassette, and routine paraffin processing. Sections (5 μm) were deparaffinized and
rehydrated, and then antigen retrieval was performed by boiling in 50 mM Tris-HCl, pH 9.0.
Slides were blocked in 1% bovine serum albumin (BSA) and 0.3% Triton X-100 in phosphatebuffered saline (PBS) and then incubated in goat anti-Calregulin (SantaCruz) followed by
AlexaFluor594 antigoat. Fluorescence microscopy and imaging were performed using a Zeiss
Axiovert 200 microscope with Axiocam MRM camera with Apotome.
For morphological analysis, 3, 5 µm sections taken 100 µm apart were stained with
hematoxylin and eosin to allow identification of islets. Whole slides were scanned with
Nanozoom microscope and the cross-sectional area of islet/total pancreas tissue was measured
across each slide using Nanozoom Digital Pathology software (Hamamatsu). Samples were
randomized, and the scorer was blinded to ensure unbiased quantification. Values are expressed
as %β-cell area.
Immunofluorescent Quantification
For quantification of ER in islets, the pancreata of HNF4α KO and littermate control
heterozygous mice were fixed, mounted and stained as described above. 16-bit images captured
in Zeiss Axiovision software were analyzed with ImageJ software as follows; Insulin positive
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regions (Santa Cruz rabbit anti-insulin) were measured as regions of interest, and mean
fluorescence intensity of the global ER marker Calregulin in each region was determined and
then subtracted from the median fluorescent intensity of acinar cell regions in the same image to
normalize fluorescence intensity on each slide. The mean fluorescent intensity was measured in
every islet in a 5µm section (three mice/condition). Analysis of Calregulin fluorescence was
restricted to the β-cell cytoplasm by excluding Hoechst-positive (nuclear) regions. After capture,
each image was assigned a random number so that subsequent fluorescent quantification was
blind relative to condition. Nuclear areas were identified by Hoescht staining, and pixels with an
intensity of >30 gray value as determined by the “plot profile” tool in ImageJ were excluded
from measurement. Hoescht-negative, cytoplasmic pixels were measured and normalized by
subtracting the mean fluorescence of the surrounding acinar tissue.

Endoplasmic Reticulum Calcium Fret measurement
INS-1 832/13 cells stably expressing the D1ER calcium sensor(Hara et al., 2014; Palmer
et al., 2004) were cultured as described above. Cells were transiently transfected with 10nM
HNF4α siRNA or scrambled control siRNA to knockdown HNF4α expression. Cells were also
treated with vehicle or 16µM 4-methyl umbelliferone 8-carbaldehyde (4µ8C) to inhibit XBP1
splicing as previously described.(Cross et al., 2012) Five days post transfection/treatment, 100k
cells were seeded in transparent bottom 96 well plates to achieve 70% confluency 6 hours premeasurement. Cells were washed twice in PBS and incubated in Krebs-Ringer buffer
supplemented with 3mM glucose immediately before measurement. To establish maximum and
minimum ER Ca2+ levels, at this time, cells were respectively treated with 10µM membrane-
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permeabalizing ionomycin and subsequently 10mM CaCl 2 or 5mM EGTA. As an additional
control for low ER Ca2+ Cells were treated with 1µM Thapsigargin to specifically diminish ER
Ca2+. FRET ratio of the D1ER cameleon was measured using the Tecan Infinite M1000Pro
microplate reader. Fluorophores were excited at 434 nm, and emission was quantified at 530nm
(YFP) and 477nm (CFP). The ratios were measured across 4 fields/well, and the values were
averaged from 4 wells per experimental condition. After FRET microplate measurement, RNA
was isolated as described above and quantified by qPCR to measure Hnf4α and Xbp1 knockdown
efficiency (Supplemental Fig. 8).

Ratiometric calcium imaging and data analysis
Studies were performed 24 hours after plating INS-1 823/13 cells at 50% confluency and
carried out at 37°C with 5% CO 2 in a perifusion chamber with a flowrate of 2mL/min. Cells
were loaded with Fura-2AM by incubation at 37°C in Krebs-Ringer buffer supplemented with
3mM glucose, 1µM Fura-2AM, and 0.1% Pluronic F-127 for 30 min, washed in HBSS, and
incubated for another 30 min to allow for ester hydrolysis. After loading, cells were imaged on
an inverted microscope (Till Photonics; Munich, Germany) equipped with a cooled CCD camera
(Cooke, Auburn Hill, MI) using a ×20/0.45 Plan Fluor objective (Nikon). The fluorescence
excitation (340 and 380 nm) was provided by a Polychrome V Monochromator (Till Photonics).
After the matching background was subtracted, the image intensities from each pair of images,
measured at 520nm, were divided by one another to yield ratio values for individual cells. [Ca2+] i
in individual cells was estimated based on the formula: [Ca2+] i = KD × B × (R − Rmin)/(Rmax −
R), where KD is the indicator's dissociation constant for Ca2+ (0.22 μM); R is ratio of
fluorescence intensity at two different wavelengths (340/380 nm); Rmax and Rmin are the ratios
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of Ca2+-free and Ca2+-bound Fura-2, respectively; and B is the ratio of the fluorescence intensity
of the second excitation wavelength at zero and saturating Ca2+ concentrations. The calibration
constants were determined as previously described,(Grynkiewicz et al., 1985) and the ratio
values were plotted against time.

Islet Isolation and Culture

Pancreatic

islets

from

CAGGCreERTM;Hnf4αfloxed/floxed

mice

and

CAGGCreERTM;Hnf4αfloxed/+ littermate controls were isolated as previously described,(Li et al.,
2009) by pancreatic duct injection of 1000 U/mL of collagenase solution (sigma) followed by
digestion at 37°C for 15 minutes with mild shaking. Islets were washed several times with
Hanks' balanced salt solution, separated from acinar cells by straining through a 100 µm filter,
viewed under a dissecting microscope, and handpicked for culture (yield = 200-300
islets/mouse). Isolated Islets were maintained in RPMI1640 supplemented with 10% FBS and
penicillin and streptomycin at 37° with 5% CO 2 . All islets were allowed to recover from
isolation for 24h before analysis. Islets were isolated from mice in random order relative to
condition.

Adenoviral transduction

Unspliced XBP1 adenovirus (Applied Biological Materials), LacZ Adenovirus (Applied
Biological Materials), and spliced XBP1 (a gift from Laurie Glimcher),(Lee et al., 2008) were
amplified in HEK293 cells, cultured as described above. Infected cells were lysed by three
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cycles of freezing and thawing and then centrifuged. Viral titer was determined by infecting
HEK-293 cells with serially diluted viral stock and overlaying with agar and subsequently
counting the resulting plaques. INS-1 cells containing dnHNF4α were treated with doxycycline
or vehicle to induce expression of dnHNF4α as described above. Five days post-treatment, cells
were infected with either XBP1u or LacZ adenovirus at a multiplicity of infection (MOI) of 100.
Viral stock was replaced with complete medium after 2 hours of infection. Isolated murine islets
were infected as described previously.(Muniappan and Ozcan, 2009) Briefly, 70 islets/condition
were washed in cold PBS, pretreated with HBSS containing 2 mM EGTA at 37° with 5% CO 2
for 15 min, then infected with adenovirus in serum-free RPMI 1640. Following a15 min
incubation, complete medium was added to islet culture. Islets were infected for 24 hr before
GSIS assay and harvesting RNA. Adenovirus was used in isolated islets at the following MOIs
(Supplemental Fig. 8): LacZ MOI=50, XBP1u MOI=50, XBP1s MOI=10.

Glucose-Stimulated Insulin Secretion Measurement
For INS-1 GSIS assay, 2 days post-adenoviral infection cells were washed with PBS,
then incubated for one hour in Krebs-Ringer Buffer containing 3mM glucose. After one hour,
cells were washed with PBS, and basal insulin secretion was measured by incubating cells for
one hour in Krebs-Ringer Buffer containing 3mM glucose. Media were sampled, then replaced
with media containing 16.7 mM glucose, or 200µM Tolbutamide for one hour. Media were
collected and analyzed for insulin content by ELISA using the Singulex Erenna platform by the
Washington University Diabetes Research Center Immunoassay Core. Static GSIS was similarly
measured in isolated islets as previously described.(Nolan and O'Dowd, 2009) 24h post
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infection, fifty islets were placed in Krebs-Ringer Buffer containing 3mM glucose to measure
basal insulin secretion, then stimulated with 16mM glucose. Insulin secretion was measured in
each condition as described above.

Graphing and statistic
All graph values represent the mean of the sample, and error bars represent SEM where
indicated. Significance was determined using student’s T-test or ANOVA with Dunnet’s
comparison as indicated. Wherever possible, samples were randomized and measurements were
blinded to prevent the introduction of experimental bias. Sample sizes were determined based on
statistical significance and practicality.
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Figure Legends
Figure 1. HNF4α is a direct transcriptional regulator of XBP1 A) Immunoprecipitation of
chromatin from 5 C57/B6 mouse pancreata with anti-HNF4α followed by qPCR (ChIP assay)
showed significant occupancy at 2 predicted binding sites in the Xbp1 promoter (but not at a
downstream intronic control site lacking a predicted HNF4α-binding motif) when compared to
normal preimmune serum controls. B) MIN6 and C.) INS-1 cells were transfected with siRNA
targeting Hnf4α or scrambled control siRNA and Hnf4α and Xbp1 mRNA was quantified by RTqPCR at 48 hours post transfection and normalized to 18S. (means±SEM of n=6 experiments
depicted, statistical significance by one-tailed Student’s t test) D) INS-1 cells stably expressing a
doxycycline-inducible Hnf4α construct that acts as a dominant negative were incubated in the
presence or absence of doxycycline for 7 days (means±SEM of n=12 experiments depicted,
statistical significance by one-tailed Student’s t test). E) Representative western blot following
activation of doxycycline inducible myc-tagged DN-HNF4α in INS-1 cells (label at right is at
the level of the specific XBP1s protein). F) Transient transfection of INS-1 cells with an HNF4α
expression vector or a GFP control plasmid and quantification of XBP1 mRNA 48 hours post
transfection. (means±SEM of n=3 experiments depicted, statistical significance by one-tailed
Student’s t test). For all figures the following symbols mean: “***” - p<0.001; “**” - p<0.01;
“*” – p <0.05.

Figure 2. HNF4α is required for XBP1 expression in vivo. Hnf4αfloxed/floxed mice under the
control of a ubiquitously-expressed CAGGCreERT promoter were treated with tamoxifen to
induce Hnf4α deletion. A) Pancreatic islets were isolated 28 days after beginning tamoxifen
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treatment (see Methods) and their RNA harvested. Expression of Xbp1, Hnf4α and the
downstream XBP1 target, Edem1, was assayed by qRT-PCR. B) Expression of other unfolded
protein response pathway transcripts, Chop, Bip, and Atf4 were assayed as for (A). C)
Immunofluorescent images of the ER marker Calregulin reveal altered ER structure in ΔHnf4α
mouse islets. Scale bars=20µm. D) Mean fluorescent intensity (arbitrary units from 16-bit
images) of non-nuclear, β-cell-specific Calregulin staining in mouse islets was determined after
normalizing each tissue section to neighboring acinar Calregulin mean fluorescence (see
Supplemental Fig. 3 and Methods for more details)

Data represent means±SEM from 3

mice/condition, significance determined by one-tailed Student’s t-test. E) Total β-cell area in the
pancreas was quantified by anti-insulin immunofluorescence from sections by completely
sectioning through whole tissue blocks of the entire embedded pancreata from ΔHnf4α and
controls (means±SEM from 6 mice/condition, significance determined by one-tailed Student’s ttest).

Figure 3. HNF4α and XBP1 are required for ER Ca2+ Homeostasis. A) qRT-PCR performed
on RNA harvested from ΔHnf4α islets as for Figure 2 for transcripts for the KATP channel genes
KIR6.2 (Kcnj11)and SUR1 (Abcc8) and the ER Ca2+ pump SERCA2b (Atp2a2) (means±SEM
from 6 mice/condition, significance determined by one-tailed Student’s t-test). B) Cartoon of the
ER Ca2+ FRET Sensor D1ER. In low Ca2+ conditions, calmodulin is conformed in a manner that
does not allow photon transfer between the 405nm excitable CFP and the unexcitable YFP
fluorophore. In high Ca2+ conditions, the CFP domain emits at a frequency to excite YFP.
Measuring the YFP(FRET):CFP ratio determines relative Ca2+ levels in the ER as opposed to
other cellular compartments. C) FRET:CFP ratio in INS-1 D1ER cells was determine to quantify
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relative ER Ca2+ levels under the following conditions: five days after transfection of Hnf4α or
scrambled siRNA; 5 days after incubation with vehicle or 4µ8c, an inhibitor of XBP1 activation;
or combinations thereof. To determine maximal detectable Ca2+ levels, FRET:CFP was
determined 1 hour following treatment with the Ca2+ ionophore Ionomycin + CaCl 2 . The
FRET/CFP of that condition was set to 1.0, and all other conditions were normalized to it. To
determine the minimal detectable ER Ca2+ levels using this assay, cells were treated with 10µM
Ionomycin + EGTA for 1 hours or 1 µM Thapsigargin. (means±SEM of n=6 experiments
depicted, statistical significance by one-tailed Student’s t test). D) Cytoplasmic [Ca2+] of
individual INS-1 cells 5 days after transfection of Hnf4α or scrambled siRNA determined by
Fura-2AM emission levels in response to 16.7mM glucose. Plots are representative of (n>50
cells;4 biological replicates; see other representative plots in Supplemental Fig. 5). E)
Cytoplasmic [Ca2+] of individual INS-1 cells 5 days after transfection of Hnf4α or scrambled
siRNA determined by Fura-2AM emission levels in response to 20mM caffeine, an agonist of
the ryanodine receptor, added to induce release of ER Ca2+ stores. Plots are representative of
(n>50 cells;4 biological replicates).

Figure 4. XBP1 is Sufficient for GSIS in ΔHnf4α β-cells. A) Glucose-stimulated insulin
secretion (GSIS) was determined by harvesting supernatant from wildtype INS-1 and
doxycycline-inducible DN-HNF4α INS-1 cells following incubation for one hour under high
(16mM) glucose conditions. Induction of dominant negative HNF4α abrogates GSIS (insulin
secretion of ~1 means no induction relative to baseline insulin secretion with 3mM glucose). All
cells were transduced by adenovirus carrying either unspliced Xbp1 or LacZ control vectors.
Note that Xbp1 transduction rescues GSIS in DN-HNF4α cells (means±SEM of n=6 experiments
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depicted, statistical significance by one-tailed Student’s t test), B) ΔHNF4α or heterozygote
control islets were cultured for 24 hours after isolation and then transduced with either LacZ or
Xbp1 vector-containing adenovirus. 24 hours later, RNA was harvested and qRT-PCR performed
for transcripts from Hnf4α, Xbp1 and two downstream transcriptional targets of XBP1, Serca2b
and Edem11 (data represent means±SEM from 3 individual islet isolations and transduction
experiments). C) Normalized GSIS was determined as for panel (A) with transduction of either
LacZ or Xbp1 vector-containing adenovirus into isolated islets. Note isolated islets from
Hnf4αΔ/Δ mice exhibit a complete lack of GSIS. (data represent means±SEM from 3 individual
islet isolations and transduction experiments) D) Model of MODYI pathology. XBP1 regulates
transcription of multiple genes like SERCA2B that induce and maintain normal ER and ER
Ca2+ function. Loss of HNF4α in patients with MODYI causes reduced XBP1 expression.
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Supplemental Fig. 1. HNF4α is necessary for XBP1 in multiple tissues. A) Quantification of
mRNA in ΔHNF4α KO embryonic (E18.5) liver tissue relative to wildtype littermates by qRTPCR.(Battle et al., 2006) (Significance was determined using student’s t-test; error bars represent
SEM of 3 mice/condition). B-D) Mouse microarray data archived in the Gene Expression
Omnibus (GEO)(Cattin et al., 2009; Hayhurst et al., 2001; Lee et al., 2003) show reduced XBP1
expression upon loss of HNF4α in multiple tissues. Expression intensity values from redundant
probes for Xbp1 in each normal and ΔHNF4α tissue were averaged together. Error bars represent
standard deviation of each biological replicate.

Supplemental Fig. 2 Transfection of Hnf4α containing mutations corresponding to those in
characterized human MODYI patients decrease XBP1 expression in vitro A) Conserved
domain analysis of HNF4α2 protein and location of mutations with respect to domains B)
Structure of the HNF4α homodimer bound to DNA as characterized previously.(Chandra et al.,
2013) Note the location of MODYI mutations, after the homo-dimer/DNA binding domain and
before the ligand binding domain, presumably allowing mutated HNF4α to function as a
dominant-negative. C) Xbp1 mRNA expression levels in INS-1 cells transiently transfected with
MODYI mutants and GFP cDNA as a control. Error bars represent standard deviation of 3
biological replicates. Significance determined by ANOVA with Dunnet’s comparison.

Supplemental Fig. 3 Diminished ER in ΔHNF4α mouse islets. A) Epifluorescent images of
the pan-ER marker calregulin in mouse islets. ΔHNF4α islets exhibit significantly altered ER. B)
Calregulin (red) and Hoescht (blue) stain of mouse islet. C) Pixel intensity along a line bisecting
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each islet shows dramatically reduced calregulin signal in the non-nuclear areas of the islet.
Integration of the Hoescht negative areas was used to determine the cytoplasmic intensity of
calregulin staining in (Fig. 2D)

Supplemental Fig. 4. Tolbutamide induced insulin secretion. Expression of a dominant
negative form of HNF4α in INS-1 cells completely abrogates increased insulin secretion in
response to tolbutamide exposure, suggesting the MODY1 secretion defect is distal to β-cell
membrane depolarization in the GSIS signaling cascade. Infection with an adenovirus carrying
Xbp1u expression vector is sufficient to rescue this GSIS defect. Dn-HNF4α INS-1 cells were
treated with doxycycline as shown in (Fig. 4A) (means±SEM of n=3 biological replicates
depicted, statistical significance by one-tailed Student’s t test)

Supplemental Fig. 5. Cytoplasmic Ca2+ signaling in ΔHNF4α β-cells. A,B) Cytoplasmic
[Ca2+] of INS-1 cells upon addition of 16.7mM Glucose or 20mM caffeine, respectively,
determined by Fura-2 excitation ratios. Plots represent cytoplasmic [Ca2+] vs time of individual
INS-1 cells, and are representative of (n>50) of each condition (4 biological replicates). Bars at
the top of each plot indicate duration of treatment.

Supplemental Fig. 6. Rescue of GSIS in ΔHNF4α islets with spliced Xbp1. A) Disruption of
Hnf4α expression reduces Xbp1 expression and the expression of downstream XBP1 targets in
ΔHnf4α mouse islets compared to heterozygous control islets. B) ΔHnf4α and heterozygote

110

control islets were isolated and treated as in (Fig. 4B) but infected with adenovirus harboring
plasmid encoding a transcript for spliced XBP1 (XBP1s). XBP1s expression is sufficient to
partially rescue GSIS in isolated ΔHNF4α islets, but GSIS (i.e. insulin release following
switching of islets to 16 mM glucose) is diminished in both WT and ΔHnf4α islets compared to
WT GSIS. LacZ vector-containing adenovirus was used as a control for transduction
(means±SEM of n=3 experiments depicted, statistical significance by one-tailed Student’s t test)

Supplemental Fig. 7. Model: HNF4α enhances XBP1 expression leading to robust ER and
proper insulin secretion in normal conditions. Loss of HNF4α leads to reduced XBP1 expression,
diminished ER calcium levels, and impaired insulin secretion in response to glucose.

Supplemental Fig. 8. A) Titration of optimal MOI of control, unspliced, or spliced XBP1
adenovirus in isolated WT mouse islets shows efficient transfer of XBP1. Islets were isolated
and cultured as described in methods, then treated with indicated levels of adenovirus before
quantifying Xbp1 expression by qPCR B) qPCR analysis of D1ER INS-1 cells used in (Fig. 3C).
Transient transfection of HNF4α siRNA efficiently knocked down expression of both Hnf4α and
Xbp1. Pharmacological inhibition of post-transcriptional Xbp1 activation with the IRE1α
inhibitor, 4µ8C had no effect on overall Xbp1 levels.

Supplemental Fig. 9 Oligonucleotides used
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Primer
ChIP -1.2 kb Hnf4-alpha site
ChIP -2.4 kb Hnf4-alpha site
ChIP intronic control site
Mouse Hnf4ɲ
Mouse Xbp1
Rat Hnf4ɲ
Rat Xbp1
Mouse Edem1
Mouse Aƞ4
Mouse Chop
Mouse Insulin
Mouse Calregulin
Mouse Hnf1ɲ
Mouse Kir6.2
Mouse Sur1
R154X HNF4ɲ
R127W HNF4ɲ

Forward Sequence
GCCCCAAGGAGACATACAGA
AAGGGCGGATGAAAAGAGTT
GGCGAGTGGTACCTCACTGT
CTGAAGGTGCCAACCTCAAT

Reverse Sequence
GGGGGATAAGTTCAGCTCCT
TTGGCAATTGGAAATTATGC
AAATGGTGGCAGCCTAGATG
CCACACATTGTCGGCTAAAC

GAACCAGGAGTTAAGAACACG AGGCAACAGTGTCAGAGTCC

CAAGAGGATTGCCAACATCA
CACAGACTGCGCGAGATAGA
CTACCTGCGAAGAGGCCG
GGGTTCTGTCTTCCACTCCA
CCACCACACCTGAAAGCAGAA
TGGCTTCTTCTACACACCCAT
AAGTTCTACGGTGACGAGGAG
ACCCATGGCGCGTGGCAAAG
CTGGCCATCCTCATTCTCAT
TCAGCAGCACATTCCGTATC

GAGCAGCACATCCTTGAACA
CCAAGCGTGTCCTTAACTCC
GTTCATGAGCTGCCCACTGA
AAGCAGCAGAGTCAGGCTTTC
AGGTGAAAGGCAGGGACTCA
CTCCAGTGCCAAGGTCTGAA
GTCGATGTTCTGCTCATGTTTC
CACCTGTGGGCTCTTCAATC
TTGGAGTCGATGACGTGGTA
GGGCCAGGAACAGAAGTACA

GAGGTCCTGTCCTGACAGATCACCTC

GAGGTGATCTGTCAGGACAGGACCTC

GAATGAGCGGGACTGGATCAGCACTC

GAGTGCTGATCCAGTCCCGCTCATTC
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CHAPTER FIVE
Conclusions and Future Directions
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HNF4α is required for Normal Cell-Differentiation in the Adult Mouse Gastric Epithelium
In Chapter Two, we show that HNF4α is required for the development and maintenance
of the gastric epithelium. We screened for enhancers of Xbp1 expression and found that HNF4α
binds the Xbp1 locus and enhances its expression. We show that HNF4α is expressed in the stem
cell and progenitor zone, pit cells, neck cells, but not in parietal cells in the gastric unit. Loss of
HNF4α results in increased proliferation and abnormal ZC differentiation in the gastric corpus.
Despite this increased proliferation in ΔHNF4α stomachs, total gastric unit size was unchanged.
We provide evidence that this loss of ZC architecture is likely due to lack of Xbp1 expression.
This is the first characterization of HNF4α in the normal stomach, and adds to our understanding
of the transcriptional network that orchestrates secretory cell development in the gastric
epithelium.(Nam et al., 2010)
The gastric unit differentiates in a highly-conserved, spatiotemporal manner.(Karam et
al., 1997) Other dedicated secretory organs don’t turn over constitutively and are arranged in
more complex, three-dimensional structures, complicating analysis of changing differentiation
patterns.

In contrast, slight aberrations in gastric unit can be quantified using simple

histological approaches. This makes it the ideal system to study the molecular mechanics of
secretory cell development. In chapter two we illustrate this powerful approach by describing
new functions of HNF4α in differentiating and maintaining secretory cell lineages.
Future directions:
We show that HNF4α is a transcriptional enhancer of Xbp1 in the stomach, and that
knockout models of both TFs have similar morphological defects. Future studies should establish
whether this transcriptional relationship is directly required for ZC differentiation. First,
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I propose measuring levels of XBP1 and downstream TF MIST1 in the gastric corpus using
western blot. This will establish whether HNF4α is required for Xbp1 expression, or whether
loss of HNF4α is causing ZC defects through a separate XBP1-independent mechanism. To
further test this, I would propose rescuing XBP1 in ZCs via ectopic expression, as previously
described in the liver.(Lee et al., 2005)If the defects in ZC differentiation are rescued, it will be
clear that HNF4α acts through enhancing Xbp1 expression in ZCs.
Chapter two shows that HNF4α is necessary for normal gastric epithelial differentiation.
While our data suggests it acts through Xbp1 to regulate ZC differentiation, the cause of the
increased proliferation in ΔHNF4α mice is unclear. To elucidate potential drivers of this
proliferation, I propose gene expression analysis using RNA-seq to identify differences between
stomachs from WT and ΔHNF4α mice. This would allow analysis of signaling pathways that are
altered upon loss of HNF4α, and determination of the role of HNF4α in isthmal progenitor cells,
where its expression is strong. Additionally, to determine if HNF4α coordinates the
differentiation of ZCs by upstream patterning in progenitor cells, or directly, in the ZC, I
propose crossing MIST1creERT mice,(Shi et al., 2009) with HNF4αfloxed/floxed mice.(Hayhurst et al.,
2001) If ZC differentiation is disrupted, it is likely due to a cell-autonomous loss of HNF4α,
rather than an upstream event.
Finally, an important next step is to understand the role of HNF4α in the
damaged/diseased gastric epithelium. I propose to measure changes in the expression of HNF4α
in WT mice in response to damage i.e. high-dose tamoxifen, Helicobacter pylori infection.
Because loss of HNF4α stimulates proliferation, I expect that HNF4α expression would be
decreased in response to damage, to allow enhanced proliferation and recovery. I further propose
histological analysis of WT and HNF4α-null mouse stomachs upon damage, and their
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subsequent recovery. If ΔHNF4α mice are more prone to severe metaplasia, it would mean that
HNF4α is required to protect the epithelium. Observing the recovery from damage will also
increase our understanding in the role of HNF4α in patterning the differentiation of specific cell
lineages in the gastric unit. These proposed experiments will explore the molecular mechanisms
of HNF4α in the regulation of gastric secretory cell development.
Identification of ANPEP as a Surface Marker for Isolation of Mature Gastric ZCs
In Chapter Three, we identify the first surface marker of mature ZCs in the gastric
epithelium, ANPEP. Our data shows that neither neck cells neither transitioning to ZCs, nor
dedifferentiated ZCs express ANPEP in human and mouse models. Importantly, by exploiting
these properties of ANPEP expression and improving on single cell isolation/FACS sorting
techniques, we are able to isolate pure populations of mature ZCs from normal mouse stomachs.
This is a significant improvement upon the current more expensive and time consuming genetic
manipulation and lineage tracing methods. Using flow cytometry to directly quantify molecular
changes in the gastric epithelium using cell-surface markers is a powerful tool to characterize
cellular changes in response to damage or disease. We observed a loss of ANPEP+ epithelial cells
in response to induction of SPEM, mirroring that observed in RNA expression, protein
expression, and human immunofluorescence. Using this method, we were able to quantify
changes in a population of progenitor cells known to proliferate in response to injury.(Khurana et
al., 2013) CD44 expression in the gastric epithelium is significantly increased upon induction of
SPEM. This observation is quantifiable by FACS, and, allows for isolation of this cell population
for further analysis. Accordingly, we were able to isolate this population and analyze its gene
expression profile using microarray analysis (Fig. 1A) We found that the isolated cells were
highly enriched in CD44 mRNA, but contained significantly less markers of mature cell lineages
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(Muc5AC-Pit, Atp4a-Parietal, Pgc/Gif-ZC, Tff2-Neck – Fig. 1B). This illustrates how powerful
and versatile our improved method is in the analysis of molecular changes in the stomach, and
enables future studies to characterize unique molecular pathways activated in specific cell
lineages, and changes in these pathways in damage/disease.
Future directions:
The identification of ANPEP as a marker of mature ZCs that’s lost in response to
damage or disease invites further exploration as to its function in ZC biology. In other tissues,
ANPEP acts as a mediator of cell-extrinsic signaling and cell migration.(Ghosh et al., 2014;
Nam et al., 2010; Villasenor-Cardoso et al., 2013) In mouse knockout models, ANPEP is
required for angiogenesis in hypoxic conditions, but no observable phenotype was found
elsewhere.(Nam et al., 2010; Rangel et al., 2007) However, the stomach was not analyzed.
Observing any disruptions in the spatiotemporally conserved differentiation of the gastric unit
would be instrumental in characterizing the role of ANPEP in ZCs. In preliminary experiments,
none of the four known inhibitors of ANPEP (Ezetimibide, Bestatin, Tosedostat, Circumin) had
any morphological effect on the gastric epithelium (data not shown).
The sorting of ZCs using ANPEP is a proof of principle for how FACS can be applied to
the characterization of the gastric epithelium. Other gastric epithelial cell lineages can be easily
isolated and characterized using our improved method. Acid secreting parietal cells, for instance,
may be sorted using the known surface marker encoded by the Atp4a gene. This technology
complements recent advances in gastric organoid culture, which may allow the culture and
characterization of organoids derived not from an entire unit, but rather from a single cell
population.(Stange et al., 2013) I propose to study the effects of known pharmacological
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methods of inducing metaplasia, e.g. Tamoxifen, DMP-777, on cultured distinct cell lineages to
better understand the fundamental drivers of the formation of SPEM.
The gastric unit is thought to be replenished from a single, multipotent progenitor stem
cell due to radiolabeling and genetic lineage tracing studies. (Bjerknes and Cheng, 2002;
Thompson et al., 1990) This cell was first identified in 1966 as a small, undifferentiated cell with
open chromatin and without granules in the isthmus of the gastric unit. (Corpron, 1966) No
specific markers have been identified for this cell, preventing the study of the signaling pathways
that govern gastric stem cell homeostasis in maintenance of the normal epithelium or that drive
injury response pathways in damaged tissue. I propose exploiting the inherent qualities of stem
cells in conjunction with our improved cell isolation technique to isolate, and characterize gastric
stem cells. Fluorescent in situ hybridization,(Hultdin et al., 1998) detection of fluorescent
hTERT (Ali et al., 2000), or identification by side population(Goodell et al., 1996) may mark the
progenitor cell population, and allow isolation for RNA analysis using RNA-seq or gene
expression microarrays. Alternatively, using flow cytometry to sort out and characterize
individual cells that proliferate in response to damage, like CD44+ cells (Fig 1A), will allow us to
better understand the gastric epithelium’s damage response pathways, and may uncover potential
markers of stem, or at least early progenitor, cells in the normal epithelium. These proposed
experiments will leverage this powerful new approach to better defining the molecular
underpinnings of the gastric secretory cell.
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Transcriptional Regulation of Xbp1 by HNF4α is Vital to Beta-Cell Function
In Chapter four, we established that HNF4α directly binds the Xbp1 promoter locus, and
is both necessary and sufficient for Xbp1 expression in pancreatic beta-cells. We recreated three
of the most common HNF4α mutations responsible for MODYI in human patients, and upon
overexpression found ~4 fold reduction in Xbp1 expression in vitro. in vivo, loss of Hnf4α leads
to loss of Xbp1, loss of downstream targets of Xbp1, and failure to maintain the extensive ER
network required for insulin secretion. Interestingly, we found that loss of Hnf4α led to a
reduction of Serca2b expression. We report that both Hnf4α and XBP1 are required to maintain
calcium homeostasis in the ER. To the best of our knowledge no one has ever linked XBP1
activity to ER calcium, despite its important role in ER maintenance. Disruption of Hnf4α
caused impaired cytoplasmic calcium signaling in response to both glucose, and caffeine, which
specifically targets the ryanodine receptor to flood the cytoplasm with calcium stored in the ER.
We hypothesize that loss of HNF4α in beta-cells leads to impaired ER calcium homeostasis,
disrupting intracellular calcium signaling in response to glucose. As previously reported, loss of
HNF4α completely ablated GSIS in isolated mouse islets. Rescuing Xbp1 expression was able to
completely restore GSIS in these islets, indicating that loss of Xbp1 expression due to HNF4α
dysfunction may be a driving factor in MODYI pathology.
It’s important to note that, congruent with our hypothesis in Chapter One, restoring
unspliced Xbp1 expression was sufficient to rescue both downstream transcriptional targets of
Xbp1 (Edem, Serca2b), and the dysfunctional GSIS in MODYI islets. This suggests that in betacells, the transcriptional regulation of Xbp1 expression is likely the major factor in the regulation
of its function, and activation of XBP1 by IRE1 is likely not the rate-limiting step in XBP1
activity. Expressing constitutively activated XBP1 in islets, effectively bypassing IRE1, resulted
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in reduced GSIS as previously reported.(Allagnat et al., 2010) These data indicate that in our
XBP1u rescue experiment, overexpression of Xbp1 is likely rescuing the deficient Xbp1 levels
caused by HNF4α disruption, and not promoting off-target, compensatory effects.
MODYI is currently treated with sulfonylureas, selective inhibitors of the KATP channel
in beta-cells.(Thanabalasingham and Owen, 2011) Gupta et. al. found that in beta-cell specific
HNF4α knockout mice, expression of the components of this KATP channel were reduced, and
provided evidence that this was because they are direct transcriptional targets of HNF4α.(Gupta
et al., 2005) Shortly thereafter, however, Miura et. al. showed that levels of both subunits
remained unchanged upon loss of HNF4α in a nearly identical system.(Miura et al., 2006) Our
data confirms these latter results. It would be paradoxical for a reduction in KATP channels to
cause impaired GSIS, as fewer KATP channels would result in a more easily depolarized
membrane and subsequent calcium signaling to release insulin.(Cartier et al., 2001) In fact,
increased KATP channel activity is a well-studied mouse-model of diabetes. (Koster et al., 2000)
We hypothesize that the mechanism of GSIS impairment in MODYI is the disruption of ER
calcium homeostasis leading to impaired intracellular calcium signaling in response to an
increase in glucose concentration.
Many type 2 diabetes patients, initially responsive to treatment with sulfonylureas,
require insulin replacement therapy as their disease progresses.(Swinnen et al., 2009) Excessive
and prolonged stimulation of insulin biosynthesis leads to beta-cell failure and death due to
chronic ER stress.(Cnop et al., 2005; Prentki and Nolan, 2006) Similarly, while MODYI
patients are responsive to sulfonylureas, many eventually require insulin therapy.(Pearson et al.,
2005) Therapeutic agents that directly target the beta-cell ER are an area of intense research, and
may improve existing approaches to managing MODYI.(Vetere et al., 2014)
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Future Directions:
In Chapter four, we show that HNF4α is required to maintain Xbp1 expression in islets,
and that this leads to a disruption of ER morphology and intracellular signaling. The next
important step, is to characterize the effect of Xbp1 loss on other members of the UPR network,
and the function of the ER. The UPR is an intricately regulated signaling network that regulates
the size and efficiency of the ER in response to increased misfolded protein accumulation and
various other cell-stress stimuli.(Schroder and Kaufman, 2005) Inhibiting different proteins in
this signaling network can result in deleterious or enhanced beta-cell function. (Wang and
Kaufman, 2012) For instance, deleting XBP1 ablates GSIS and impairs insulin processing,(Lee
et al., 2011) while deleting another key TF in the UPR, CHOP, inhibits beta-cell apoptosis and
enhances function in mouse models of diabetes.(Song et al., 2008) Because the IRE1-XBP1 arm
of the UPR is canonically thought to be responsible for response to long-term or chronic ER
stress, it is important to characterize the effect of its loss on the more acute arms of the UPR.
Preliminarily, we found that levels of Chop, Atf4, and Bip were unaffected by deletion of Hnf4α.
However, future directions should further characterize the state of activation of each arm of the
UPR. Measuring IRE1α and PERK phosphorylation, and ATF6 cleavage in ΔHNF4α islets
would be an ideal way to elucidate whether beta-cells activate the UPR to compensate for loss of
Xbp1. Because disrupted ER calcium homeostasis often leads to an accumulation of misfolded
proteins,(Fu et al., 2011) it is likely that ΔHNF4α beta-cells do have an active UPR, although
our preliminary studies don’t show any increase in apoptosis in these islets (data not shown).
While other MODYI mouse models disrupt Hnf4α expression from the early pancreatic
development stage, our model disrupts Hnf4α acutely in adult mice. This more accurately reflects
the juvenile onset of MODYI. Our model also uses a ubiquitous CAGCreert driver to knock out
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HNF4α, mirroring the systemic mutation of HNF4α in MODYI patients. We assayed GSIS in
this model ex vivo in isolated islets to allow adenoviral transduction of gene expression, and to
control for non-beta-cell-specific effects of loss of HNF4α. However, mutations in HNF4α are
also associated with dyslipidemia, renal defects, and other maladies.(Hamilton et al., 2014;
Weissglas-Volkov et al., 2006) To determine whether the GSIS defect in MODYI is islet
specific, I propose to induce islet death in WT mice with Streptozotocin, then transplant islets
from our MODYI mouse to the kidney capsule of the WT mouse. GSIS could then be measured
and compared between transplanted WT and MODYI islets. Additionally, WT islets could be
transplanted into the kidney capsule of ΔHNF4α mice, to see if systemic disruption of Hnf4α has
any non-islet-specific effect on glucose-tolerance or insulin secretion.
Calcium homeostasis in the ER is known to be important multiple human diseases e.g.
diabetes, neurodegenerative disorders, cancer.(Sammels et al., 2010) Inflammation models have
shown that activation of XBP1 leads to expansion of ER calcium stores in bronchial secretory
cells.(Martino et al., 2009) Our data indicates that XBP1 activity is required for ER calcium
homeostasis, a predictable, but a novel clue into how XBP1 functions the development and
maintenance of the ER. Further studies should endeavor to define the molecular mechanism of
this regulation. Previous work has shown that overexpression of Xbp1 in the liver leads to an
increase in expression of the main ER calcium pump, Serca2b.(Park et al., 2010) Our data
shows that loss of Xbp1 due to loss of HNF4α reduces Serca2b expression 2-fold, and that
restoring Xbp1 is sufficient to rescue this expression. Future experiments should characterize
whether XBP1 is a direct regulator of Serca2b, or whether this observation is a non-specific
effect of XBP1 activation. Modulation of ER calcium is a particularly attractive therapeutic
target in many human pathologies. To define the role of ER calcium in our MODYI model,
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ΔHNF4α islets should be treated with pharmacological agents to modulate ER calcium levels.
Depleting ER calcium stores by inhibiting SERCA2b with thapsigargin reduces GSIS, similar to
our MODYI model.(Vangheluwe et al., 2005)

ER calcium release is mainly mediated by the

ryanodine receptors.(Berridge et al., 2003)

Modulators of these receptors such as small

molecules derived from 1,4-benzothiazepines restore intracellular calcium stores and have been
used therapeutically in mouse models to treat cardiac arrhythmias attributed to depleted ER
calcium.(Lehnart and Marks, 2007; Lehnart et al., 2006) I propose treatment of our MODYI
islets with these modulators of the ryanodine receptor to bolster ER calcium stores and observing
their effect on GSIS and cytoplasmic calcium signaling. If these small molecules are able to
rescue the beta-cell defects caused by loss of HNF4α, they may represent a new avenue of
treatment for MODYI patients.
In addition to modulating ER calcium as a strategy to alleviate MODYI beta-cell
dysfunction, I propose further study of the ability of these cells to handle ER stress, and the
functionality of the ER itself. Preliminary data shows that insulin mRNA levels were
unchanged in ΔHNF4α islets, but further work is needed to characterize the folding and
processing of insulin. In MODYI patients, basal insulin secretion is unaffected, and in mouse
models of MODYI islet insulin content is unchanged.(Gupta et al., 2005; Miura et al., 2006)
Measuring the levels of insulin/proinsulin in WT and ΔHNF4α islets in our system would
determine whether the major beta-cell secretory protein is being properly synthesized/processed,
or whether abnormal insulin production contributes to the impaired glucose response. Small
molecule chaperones, such as 4-PBA and TUDCA, have been used to alleviate the negative
effects of ER stress in mouse models of diabetes,(Ozcan et al., 2006) obesity,(Basseri et al.,
2009) and Alzheimer’s disease.(Ricobaraza et al., 2009) They function by assisting proper
protein folding
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and processing, reversing the adverse effects of ER stress caused by accumulated misfolded
proteins. Increasing ER capacity pharmacologically could partially rescue the diminished ER
caused by lack of Xbp1, and may ameliorate impaired MODYI GSIS.
The work in Chapter Four exploits genetic tools to characterize the role of HNF4α in
Xbp1 regulation. The next step forward is to translate these findings into human MODYI
models. The functional targets of HNF4α are thought to be highly-conserved between mouse
and human,(Boj et al., 2009) and disrupting HNF4α in mouse islets mirrors the pathology of
human MODYI patients, therefore we predict that our mechanistic findings will apply to human
MODYI. The best system to test human MODYI would be in isolated islets from MODYI
patients. However, the low diagnoses rates of MODYI make this approach unfeasible. I propose
generating MODYI beta-cells from induced pluripotent stem cells. Well established methods
(Hua et al., 2013; Stepniewski et al., 2015) could be combined with the recent advances in
genome editing using the CRISPR-Cas system,(Musunuru, 2013) could be used to create betacells expressing HNF4α containing the most prevalent MODYI mutations, as we did in vitro in
beta-cell cancer cell lines. ER development, Xbp1 levels, GSIS, and calcium signaling should
all be characterized to determine whether our model mirrors human MODYI. This system could
also be used to screen for pharmaceutical compounds with potential to restore GSIS in humans.
In sum, these experiments will define the role of HNF4α in beta-cells, both in humans and
mouse models, and may identify new strategies to treat beta-cell dysfunction in MODYI
patients.
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Final Remarks
The goal of this dissertation was to understand the molecular processes that guide the
differentiation of a cell from a simple, proliferative-progenitor cell, to a highly-complex,
dedicated secretory cell. This led me to uncover a novel transcriptional relationship with an
important role in the gastric epithelium, and likely many other secretory tissues. This effort to
better understand these professional secretory cells led to the development of new tools to isolate
them from heterogeneous populations, which will open the doors to future work that will
characterize their molecular underpinnings. Finally, uncovering this signaling cascade in the
stomach, led to the answer of the decades-old question of what causes beta-cell dysfunction in
MODYI, a finding which will hopefully open new avenues to the treatment and prevention of
this prevalent human disease.
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Figure 1. Isolation of CD44-positive cells from the gastric epithelium. A) Comparison of
unstained and stained, EpCAM-positive CD44 cells, plotted vs. autofluorescence. B) Gene
expression enrichment analysis of markers of mature gastric epithelial cell lineages from CD44+,
EpCAM+ cells isolated from (A) compared to CD44ˉ, EpCAM+ cells.
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